{
"consolidatedKnowledge": {
"fund_overview_and_terms": {
"attributedTrackRecord": "John Celenza scaled Bio Steel to over $140 million in revenue, and key executives have run corporations valued at $600 million+.",
"classificationReasoning": "The provided presentation represents a corporate investment opportunity in an operating company rather than a traditional private equity, venture capital, or real estate fund.",
"diversityClaims": [],
"domicile": "Canada",
"fundName": "Harbour Solutions Importation Inc.",
"fundSeries": "I",
"isFirstTimeFund": true,
"isOpenEnded": false,
"keyRiskDisclosures": [
"Speculative Nature",
"Lack of Liquidity",
"Capital Requirements",
"Regulatory and Licensing Risks",
"Legal Uncertainty",
"Banking and Financial Services Access",
"Insurance Risks",
"Third-Party Reliance",
"Public and Legislative Acceptance"
],
"managementCompany": "Harbour Solutions Importation Inc.",
"managerClassification": "Established",
"maturityClassificationReasoning": "The management team has over 50 years of cumulative experience, with key executives having experience running corporations valued at $600 million+.",
"primaryAssetClass": "Unknown",
"regulatoryExemptions": [],
"vintageYear": "2024"
},
"strategy_and_portfolio": {
"analystSummary": "Harbour Solutions Importation Inc. positions itself as a first-mover by establishing the first authorized Canadian channel to import and process legal Peruvian coca leaves, effectively breaking a long-standing U.S. monopoly. Leveraging an exclusive, state-sanctioned five-year supply agreement with Peru's ENACO, the company separates raw leaves into high-margin pharmaceutical alkaloids and decocainized flavoring extracts for global consumer brands. Backed by key Canadian regulatory relationships and municipal support, the company operates a capital-light, partner-driven model designed to capture substantial share across multi-billion dollar verticals ahead of its planned Q1 2024 public listing.",
"assetClass": "Private Equity",
"capitalRecycling": "Not specified",
"coInvestmentRights": "Not specified",
"concentrationLimits": "Not specified",
"dealSourcingStrategy": "Securing a historic, legally binding, exclusive 5-year trade agreement with ENACO (Empresa Nacional de la Coca), the Peruvian state-run corporation which controls the oldest and largest legal source of coca leaves globally [Page 3, Page 13, Page 14].",
"illustrativeScenarios": [],
"investmentThesis": "The core investment thesis relies on extracting and separating the coca leaf's compounds into two highly valuable revenue streams: Active Compounds (Alkaloids) sold directly to authorized pharmaceutical companies for medicinal applications, and Non-Active Compounds (Decocainized Extracts) used as flavorings and bio-functional ingredients in global consumer packaged goods (CPG) with zero psychoactive effects [Page 5, Page 19, Page 23].",
"keyClaims": [
"Secured a historic, legally binding 5-year exclusive trade agreement with Peru's ENACO, backed by over 35,000 registered local coca leaf farmers [Page 3, Page 14].",
"Positioned as the first Canadian source of legal coca leaves and derivative products, dismantling a long-standing U.S. monopoly held by Stepan Company [Page 3, Page 10, Page 11].",
"Targets a $344 billion global pharmaceutical market and a $1.0 trillion+ global consumer goods market [Page 3, Page 5].",
"Active Pharmaceutical Ingredients (APIs) are projected to deliver a 20x ROI, while Decocainized Extracts operate at a ~80% gross margin [Page 3].",
"Formally supported by the municipal government of Brampton, Ontario, providing an endorsement to build a processing facility and global headquarters in a key logistics hub [Page 12, Page 22].",
"Partnered with top-tier legal team Gowling WLG to navigate complex sovereign-level compliance, pharma, biotech, and mergers & acquisitions [Page 21]."
],
"leadInvestorStatus": "Other",
"leverageLimits": "Not specified",
"modelAssumptions": [
"Active Pharmaceutical Ingredients (APIs) deliver a 20x ROI [Page 3]",
"Decocainized Extracts operate at a ~80% gross margin [Page 3]",
"Organic Fertilizers operate at a ~50% to 60% gross margin [Page 3]"
],
"primaryObjective": "Disrupting monopolistic multi-billion dollar markets by introducing competition to a space previously monopolized by a single U.S.-based entity, Stepan Company [Page 3, Page 10].",
"qualitativeThemes": [
"Market Disruption",
"Regulatory Exclusivity & Compliance",
"Capital-Light Scale",
"Sovereign Strategic Partnerships"
],
"targetGeographies": [
"Canada",
"Peru"
],
"targetReturns": {
"cashYield": {
"is_applicable": false,
"not_applicable_reason": "Not specified for this corporate equity investment opportunity"
},
"grossIrr": {
"is_applicable": false,
"not_applicable_reason": "Not specified for this corporate equity investment opportunity"
},
"grossMoic": {
"is_applicable": true,
"not_applicable_reason": "Not specified for this corporate equity investment opportunity in aggregate, though specific segment ROI is modeled [Page 3]. Only individual product ROI is provided, not fund-level MOIC."
},
"netIrr": {
"is_applicable": false,
"not_applicable_reason": "Not specified for this corporate equity investment opportunity"
},
"netMoic": {
"is_applicable": false,
"not_applicable_reason": "Not specified for this corporate equity investment opportunity"
}
},
"targetSectors": [
"Pharmaceuticals",
"Consumer Packaged Goods (CPG)",
"Nutraceuticals",
"Functional Beverages",
"Cosmetics",
"Organic Fertilizers"
],
"targetStages": [
"Growth Equity",
"Pre-IPO"
],
"valueCreationPlaybook": [
"Importing raw leaves from ENACO under strict government regulations, executing secure transit, and processing them in a certified Canadian facility [Page 23].",
"Separating raw leaves into an Alkaloid Rich Extract (for pharmaceuticals) and an Alkaloid Free Extract (for commercial CPG applications) [Page 19, Page 23].",
"Deploying a capital-light business model through strategic manufacturing and co-packing partnerships instead of heavy capital expenditures [Page 12].",
"Leveraging formal support from the municipal government of Brampton, Ontario to build a processing facility and establish its global corporate headquarters near key logistical stakeholders [Page 12, Page 22]."
]
},
"team_and_track_record": {
"additionalTeamMembers": [
{
"firstName": "Harpreet",
"lastName": "Hansra",
"title": "Political Liaison, Canada"
}
],
"advisorsAndOperatingPartners": [
{
"firstName": "Gianpaolo",
"lastName": "Caporiccio",
"title": "Advisor"
},
{
"firstName": "Peter E.",
"lastName": "Simeon",
"title": "Legal Advisor / Partner at Gowling WLG"
},
{
"firstName": "John",
"lastName": "Celenza",
"title": "Advisor"
}
],
"caseStudies": [
{
"companyName": "Stepan"
},
{
"companyName": "Power Leaves Corp.",
"currentOrExitValuation": {
"currency": "USD",
"exact_amount": {
"amount": 100,
"magnitude": "MILLIONS"
},
"normalized_exact_amount": 100000000,
"source_number_text": "$100 million",
"unit": "MONETARY"
}
}
],
"firmLeadership": [
{
"firstName": "David",
"lastName": "Craig",
"title": "Chief Executive Officer"
},
{
"firstName": "Alexander",
"lastName": "Strezos",
"title": "Chief Operating Officer"
},
{
"firstName": "Setti",
"lastName": "Coscarella",
"title": "Vice President of Corporate Strategy"
},
{
"firstName": "Alvaro",
"lastName": "Concha",
"title": "VP Corporate Development; Latin America"
}
],
"keyPrincipals": [],
"performanceAsOfDate": "Not specified",
"priorVehicles": []
},
"warehoused_deals": {
"pipelineCompanies": [
{
"coInvestors": [],
"companyName": "Enaco",
"description": "Empresa Nacional de la Coca, the Peruvian state-run coca leaf production company with an officially signed 5-year long-term international supply agreement with auto-renewal.",
"headquarters": "Peru",
"sector": "Agriculture",
"source": "Proprietary",
"status": "Closed"
}
]
}
},
"deckText": "",
"extractedSecEntities": {
"claimed_aum": "null",
"corporate_names": [
{
"name": "Harbour Solutions Importation Inc.",
"rationale": "Identified in the fund_overview_and_terms as both the fund name and the management company."
},
{
"name": "Gowling WLG",
"rationale": "Identified as the legal partner firm providing advisory services to the company."
},
{
"name": "Stepan Company",
"rationale": "Identified as the U.S.-based entity that currently holds a monopoly in the market, which the company is competing against."
},
{
"name": "Empresa Nacional de la Coca (ENACO)",
"rationale": "Identified as the Peruvian state-run corporation and primary supply partner."
}
],
"fund_names": [
{
"name": "Harbour Solutions Importation Inc. Fund Series I",
"rationale": "Derived from the combination of the management company name and the specific fund series mentioned in the fund_overview_and_terms."
}
],
"headquarters_city": "Brampton",
"headquarters_state": "Ontario",
"website": "null"
},
"extractions": [
{
"markdown_content": "# fund_overview_and_terms\n\n### Executive Summary & Note on Entity Structure\nThe provided presentation represents a corporate investment opportunity in an operating company rather than a traditional private equity, venture capital, or real estate fund. Consequently, the terms, structure, and risk management criteria below reflect the corporate organization, regulatory classification, and pathway to liquidity for **Harbour Solutions Importation Inc.**, serving as the functional equivalent of a fund's structural terms [Page 2].\n\n---\n\n### Corporate Identity & Management Company\n* **Formal Entity Name:** Harbour Solutions Importation Inc. (referred to as \"the Company\" or \"Harbour\") [Page 2].\n* **Headquarters & Domicile:** Headquartered and domiciled in Canada [Page 3, Page 12].\n* **Management Maturity & Experience:** \n * Described as \"Seasoned executive management and advisory\" with over 50 years of cumulative regulatory, CPG, capital, and public market experience [Page 3].\n * Key executives have experience running corporations valued at $600 million+ [Page 3]. \n * Notable leadership includes John Celenza, Co-Founder of Bio Steel, who previously scaled that brand to over $140 million in revenue [Page 3].\n * The operations team has a track record of successfully securing cultivation and processing licenses from Health Canada in regulated substance markets (specifically Cannabis) [Page 15].\n\n---\n\n### Investment Strategy & Offering Terms\n* **Asset Class / Industry Focus:** Agriculture, Biotechnology, Pharmaceuticals, and Consumer Packaged Goods (CPG) focused on the legal importation, processing, and distribution of the *Erythroxylum coca* (coca plant) and its active/non-active derivatives [Page 1, Page 5].\n* **Business & Capital Deployment Model:** \n * \"Capital light business model\" wherein Harbour deploys capital to build revenue through strategic partnerships rather than committing to major capital expenditures [Page 12].\n * The supplier serves as a manufacturer, providing a short path to commercialization via immediate co-packing options [Page 3].\n* **Target Verticals & Market Size:**\n * **Active Pharmaceutical Ingredients (APIs):** Target addressable pharmaceutical market size of $344 billion (including Diet & Weight Loss at $175.2B, ADHD Medication at $32.24B, Local Anesthetics at $2.6B, Anti-Inflammatory Medications at $111.42B, and Vasoconstriction in Capillaries at $6B) [Page 3, Page 5].\n * **Consumer Goods (Non-Active Compounds):** Target addressable market of $1 Trillion+ (including Energy Drinks at $53.1B, Global Functional Foods at $305.4B, Nutraceuticals at $423B, and Beauty & Personal Care at $579B) [Page 3, Page 5].\n * **Commercial Fertilizer:** Target addressable market of $268 billion [Page 5] (elsewhere referenced as a $200 billion market [Page 3, Page 18]).\n* **Pathway to Liquidity (Fund Life / Horizon Equivalent):** \n * The Company has a public listing planned via a Reverse Takeover (RTO) scheduled for Q1 2024 [Page 3].\n\n---\n\n### Key Legal, Regulatory, and Government Entities\n* **Legal Advisor:** Gowling WLG, which provides legal representation, assists in navigating compliance requirements, and facilitates strategic value chain partnerships [Page 15, Page 21]. Peter E. Simeon is named as Partner at Gowling WLG and Legal Advisor to Harbour [Page 15].\n* **Regulatory Oversight Bodies:** Harbour collaborates and maintains ongoing regulatory discussions with:\n * Health Canada [Page 12, Page 15, Page 23]\n * Canadian Food Inspection Agency (CFIA) [Page 12]\n * Royal Canadian Mounted Police (RCMP-GRC) [Page 12]\n * Canada Border Services Agency (CBSA) [Page 12]\n* **Strategic Supply Partner:** ENACO (*Empresa Nacional de la Coca*), the Peruvian state-run coca leaf corporation [Page 13, Page 14]. \n * Harbour has officially signed a 5-year international supply agreement with ENACO featuring an automatic renewal clause [Page 14].\n * The agreement includes negotiated \"preferential pricing\" for all coca leaves and coca leaf derivative products [Page 14].\n * ENACO represents a network of over 35,000 registered local coca leaf farmers in Peru [Page 3, Page 14].\n* **Municipal Government Partner:** City of Brampton, Ontario, Canada [Page 22].\n * Brampton Mayor Patrick Brown issued a formal Letter of Support dated April 19, 2023, endorsing Harbour's intention to establish its major processing facility and global corporate headquarters in the municipality [Page 22].\n\n---\n\n### Regulatory Exemptions & Operational Status\n* **Exemptions & First-Mover Status:** \n * Successfully legally imported decocainized coca leaf extract into Canada/North America for commercialization [Page 3, Page 12].\n * Positioned as the first Canadian source of coca leaves and their derivative products, challenging the existing US monopoly held by Stepan [Page 10, Page 11, Page 20].\n * Operational framework is aligned with the Canadian government's ongoing investigation into alternative frameworks to prevent harm caused by opioids (\"Safe Supply\" initiatives) [Page 3, Page 24].\n\n---\n\n### Explicit Risk Disclosures for Investors\nAccording to the formal Legal Disclaimer, potential investors are subject to the following key risks [Page 2]:\n* **Speculative Nature:** Investments in the Company are speculative and carry no guarantee of performance or returns [Page 2].\n* **Lack of Liquidity:** There is currently no liquid market for the Company's securities [Page 2].\n* **Capital Requirements:** The Company requires additional funding to execute its business strategies [Page 2].\n* **Regulatory and Licensing Risks:** The business is highly dependent on securing, maintaining, and complying with required licenses, permits, and authorizations from various levels of government [Page 2].\n* **Legal Uncertainty:** Risks associated with changes in local or international laws, or the non-occurrence of anticipated legal/policy changes [Page 2].\n* **Banking and Financial Services Access:** Risks of potential denial of banking services due to the specific regulatory nature of the industry in which the Company operates [Page 2].\n* **Insurance Risks:** Risks related to the denial of insurance coverage or the inability to obtain insurance coverage at reasonable rates [Page 2].\n* **Third-Party Reliance:** Heavy operational reliance on third-party suppliers and partners (such as ENACO) [Page 2, Page 13].\n* **Public and Legislative Acceptance:** Operational success is subject to acceptance by the general public and legislators [Page 2].",
"schema_name": "fund_overview_and_terms",
"structured_data": {
"attributedTrackRecord": "John Celenza scaled Bio Steel to over $140 million in revenue, and key executives have run corporations valued at $600 million+.",
"classificationReasoning": "The provided presentation represents a corporate investment opportunity in an operating company rather than a traditional private equity, venture capital, or real estate fund.",
"diversityClaims": [],
"domicile": "Canada",
"fundName": "Harbour Solutions Importation Inc.",
"fundSeries": "I",
"isFirstTimeFund": true,
"isOpenEnded": false,
"keyRiskDisclosures": [
"Speculative Nature",
"Lack of Liquidity",
"Capital Requirements",
"Regulatory and Licensing Risks",
"Legal Uncertainty",
"Banking and Financial Services Access",
"Insurance Risks",
"Third-Party Reliance",
"Public and Legislative Acceptance"
],
"managementCompany": "Harbour Solutions Importation Inc.",
"managerClassification": "Established",
"maturityClassificationReasoning": "The management team has over 50 years of cumulative experience, with key executives having experience running corporations valued at $600 million+.",
"primaryAssetClass": "Unknown",
"regulatoryExemptions": [],
"vintageYear": "2024"
}
},
{
"markdown_content": "# Strategy and Portfolio\n\n### Executive Analyst Summary\nHarbour Solutions Importation Inc. positioning as the first authorized Canadian importer and processor of legal Peruvian coca leaves presents a highly lucrative, first-mover opportunity to dismantle a long-standing U.S. monopoly in the multi-billion dollar active and non-active compound markets. By securing a historic, exclusive five-year state-sanctioned supply agreement with Peru's ENACO, Harbour mitigates critical regulatory barriers and establishes a capital-light, high-margin business model designed to supply both the $344 billion pharmaceutical API sector and the $1 trillion+ consumer packaged goods market. Backed by experienced municipal, political, and regulatory leaders, the company is poised to capture significant market share across multiple verticals, including functional beverages, cosmetics, nutraceuticals, and organic fertilizers, ahead of a planned public listing. [Page 1, Page 2, Page 3, Page 10, Page 11, Page 12]\n\n---\n\n### Core Qualitative Narrative and Investment Thesis\n\n#### Primary Investment Objective & Thesis\n* **Disrupting Monopolistic Multi-Billion Dollar Markets**: Harbour aims to capitalize on a \"once-in-a-generation\" market opportunity by introducing competition to a space previously monopolized by a single U.S.-based entity, Stepan Company [Page 3, Page 10]. \n* **The \"First-Mover\" Advantage in Canada**: Harbour is positioned as the first Canadian source of coca leaves and their derivative products [Page 11]. This enables Canadian and international brands to tap into the therapeutic and flavor profiles of the coca plant legally in North America [Page 8, Page 11].\n* **Active vs. Non-Active Compound Bifurcation**: The core investment thesis relies on extracting and separating the coca leaf's compounds into two highly valuable revenue streams:\n * *Active Compounds (Alkaloids)*: Sold directly to authorized pharmaceutical companies for medicinal applications [Page 5, Page 19, Page 23].\n * *Non-Active Compounds (Decocainized Extracts)*: Used as flavorings and bio-functional ingredients in global consumer packaged goods (CPG) with zero psychoactive effects [Page 5, Page 19, Page 23].\n\n#### Market Opportunities & Addressable Markets\n* **Total Addressable Pharmaceutical Market**: Valued at **$344 billion** globally (as of 2022) [Page 3, Page 5]. Specific addressable medical applications include:\n * Diet & Weight Loss: **$175.2 billion** [Page 5]\n * ADHD Medication: **$32.24 billion** [Page 5]\n * Anti-Inflammatory Medications: **$111.42 billion** [Page 5]\n * Vasoconstriction in Capillaries: **$6.0 billion** [Page 5]\n * Local Anesthetics: **$2.6 billion** [Page 5]\n* **Total Addressable Consumer Goods Market**: Valued at **$1.0 trillion+** globally (as of 2022) [Page 3, Page 5]. Specific addressable categories include:\n * Beauty & Personal Care: **$579.0 billion** [Page 5]\n * Nutraceuticals: **$382.0 billion** to **$423.0 billion** [Page 4, Page 5]\n * Global Functional Foods: **$275.0 billion** to **$305.4 billion** [Page 4, Page 5]\n * Fertilizers for Commercial Agriculture: **$200.0 billion** to **$268.0 billion** [Page 3, Page 5, Page 18]\n * Energy Drinks: **$50.0 billion** to **$53.1 billion** [Page 4, Page 5]\n\n#### Sourcing Strategies & Global Partnerships\n* **State-Sanctioned Monopolistic Partnership**: Harbour has secured a historic, legally binding trade agreement with **ENACO** (Empresa Nacional de la Coca), the Peruvian state-run corporation which controls the oldest and largest legal source of coca leaves globally [Page 3, Page 13, Page 14].\n* **Agreement Scope and Farmers Network**: The international supply agreement is a **5-year contract with automatic renewal** [Page 14]. This contract directly supports and sources from a network of over **35,000 registered local Peruvian coca leaf farmers** [Page 3, Page 14].\n* **Preferential Pricing**: Harbour has negotiated preferential, exclusive pricing structures with ENACO for all raw coca leaves and derivative products [Page 14].\n* **Ratification and Legality**: The trade agreement was fully ratified by the Peruvian Congress, assuring sovereign-level legal protection and compliance [Page 12].\n\n#### Value Creation Playbook & Operating Model\n* **The Decocainization & Extraction Loop**: The proprietary extraction process consists of importing raw leaves from ENACO under strict government regulations, executing secure transit, and processing them in a certified Canadian facility [Page 23].\n * *Step 1*: Raw leaves go into the Coca Extractor [Page 19].\n * *Step 2*: Separation into an Alkaloid Rich Extract and an Alkaloid Free Extract [Page 19].\n * *Step 3*: The Alkaloid Rich Extract yields active pharmaceutical compounds [Page 19, Page 23].\n * *Step 4*: The Alkaloid Free Extract is processed into high-margin liquid or powder extracts for commercial CPG applications [Page 19, Page 23].\n* **Capital-Light Business Model**: Instead of executing major capital expenditures, Harbour deploys its capital to generate revenue through strategic manufacturing and co-packing partnerships [Page 12].\n* **Turnkey Co-Packing Capabilities**: The Peruvian supplier also acts as a manufacturer, offering immediate co-packing opportunities that drastically shorten the traditional path to commercialization [Page 3].\n\n#### GP Competitive Edge & Barriers to Entry\n* **Regulatory Exclusivity & Compliance**: Harbour operates with full compliance under municipal, provincial, and federal regulations [Page 13]. The operations team possesses a proven track record of securing cultivation and processing licenses from **Health Canada** in complex regulated substance markets (e.g., Cannabis) [Page 15].\n* **Strong Political Currency**: Harbour has obtained significant political and law enforcement support in Canada [Page 20]. The company is actively collaborating with regulatory bodies, including Health Canada, the Canadian Food Inspection Agency (CFIA), the Royal Canadian Mounted Police (RCMP), and the Canada Border Services Agency (CBSA) [Page 12].\n* **Sovereign Legal Advisory**: Legal representation and compliance navigation are led by **Gowling WLG**, a top-tier legal team specializing in pharma, biotech, and complex mergers & acquisitions [Page 21].\n* **Municipal Infrastructure Support**: Harbour has received formal support from the municipal government of Brampton, Ontario [Page 12, Page 22]. In a Letter of Support dated April 19, 2023, Mayor Patrick Brown endorsed Harbour's plans to build a processing facility and establish its global corporate headquarters in Brampton, highlighting its role as a key logistics hub near stakeholders like Coca-Cola and Sun Pharmaceuticals [Page 22].\n\n---\n\n### Portfolio Construction Parameters & Business Model\n\n#### Three Main Verticals & Product Offerings\nHarbour builds its portfolio around three core operational verticals [Page 3]:\n\n| Vertical | Market Size | Portfolio Parameters & Core Offerings |\n| :--- | :--- | :--- |\n| **Active Pharmaceutical Ingredients (APIs)** | $344 Billion [Page 3] | • Alkaloids sold to pharmaceutical firms for prescription therapeutics.<br>• Target uses: Diet/weight loss, ADHD meds, local anesthetics, anti-inflammatories [Page 5]. |\n| **CPG Brand Ingredients & Direct Brands** | $1 Trillion+ [Page 3] | • Supplying decocainized flavorings to blue-chip global brands [Page 12, Page 16].<br>• Launching proprietary in-house brands: \"Ratio\" (Pure Plant Protein) and \"Constitution Nutraceuticals\" (Whole Body Vitality) [Page 29, Page 30, Page 34].<br>• Launching a portfolio of nootropic lifestyle beverages [Page 3, Page 31, Page 32, Page 33]. |\n| **Fertilizer Ingredients** | $200 Billion [Page 3] | • Commercial-grade organic liquid fertilizers produced locally in Canada [Page 18].<br>• Promotes higher crop yields relative to traditional nitrogen fertilizers [Page 18]. |\n\n#### Target Geographies and Regulatory Frameworks\n* **Canada as a Launchpad**: Harbour is headquartered in Canada, leveraging the country's position as one of the first G7 nations to actively explore the descheduling of controlled substances [Page 3]. \n* **Safe Supply Movement Exemption**: The city of Vancouver has already received exemptions to deschedule drugs, with proposals under consideration to expand this framework nationwide [Page 3]. Harbour is positioned to satisfy the government's need for a safe, non-organized-crime-affiliated supply chain of raw materials [Page 3].\n* **Federal Framework Alignment**: Harbour is structuring its operations to align with the Canadian government's ongoing investigation into safe frameworks to prevent harm caused by synthetic opioids [Page 24].\n\n#### Partnerships and Customer Target Architecture\nHarbour has structured its business model to target two clear segments of enterprise customers [Page 23]:\n\n```\n [Raw Coca Leaf Importation (ENACO)]\n │\n [Secure Transport Link]\n │\n [Canadian Processing Hub]\n ┌┴┐\n ┌───────────────────────────┘ └────────────────────────────┐\n ▼ ▼\n [Active Compounds (Alkaloids)] [Non-Active Extracts]\n │ │\n ┌────────┴────────┬────────┐ ┌────────┬───────┼────────┬───────┐\n ▼ ▼ ▼ ▼ ▼ ▼ ▼ ▼\n[Sun Pharma] [Apotex] [GSK] [Coca-Cola] [Cott] [Redbull] [Aesop] [Lush]\n```\n\n* **Target Pharma API Clients**: Includes Johnson & Johnson ($96.26B revenue), Bayer ($47.5B revenue), AstraZeneca ($44.35B revenue), Merck ($42.84B revenue), Pfizer ($18.28B revenue), Sun Pharma ($5.1B revenue), Apotex ($1.2B revenue), and GSK ($1.07B revenue) [Page 9, Page 23].\n* **Target Non-Active Extract Clients**: Includes Coca-Cola ($43B revenue), Redbull ($10.2B revenue), Cott Beverage/Walmart ($2B revenue), LUSH ($1.06B revenue), Tom Ford ($654M revenue), and Aesop ($537M revenue) [Page 8, Page 23].\n\n---\n\n### Financial Models & Projected Returns\n\n#### Modeled Margins and Projected Returns\nThe company's commercialized offerings are characterized by exceptionally high return-on-investment (ROI) structures and gross margin profiles at scale [Page 3]:\n* **Active Pharmaceutical Ingredients (APIs)**: Projected to deliver a **20x ROI** [Page 3].\n* **Decocainized Extracts**: Projected to operate at a **~80% gross margin** [Page 3].\n* **Organic Fertilizers**: Projected to operate at a **~50% to 60% gross margin** [Page 3].\n\n#### Key Comparables and Competitive Valuation\nHarbour's competitive analysis features two primary comparables to highlight its valuation and market potential [Page 10]:\n* **Stepan Company (US)**:\n * *Revenue & Status*: A US-owned, publicly traded company (based in New Jersey/New York) generating **$2.2 billion in annual revenue** [Page 10].\n * *Role*: Historically, the *only* legal importer of coca leaves from Peru to North America. Stepan processes the leaves, sells the flavor extracts to Coca-Cola, and sells the extracted active alkaloid compounds to Mallinckrodt (a pharmaceutical firm with $3.2 billion in 2019 revenue) for medicinal use [Page 10].\n * *Implication*: Stepan represents a direct model of Harbour's operational strategy, confirming the viability of a dual-revenue extraction business [Page 10, Page 23].\n* **Power Leaves Corp. (Colombia)**:\n * *Valuation & Status*: A Colombia-based, pre-revenue start-up valued at **$100 million** [Page 10].\n * *Role*: Processors of Colombian coca leaves with plans to export decocainized extracts internationally [Page 10].\n * *Implication*: Demonstrates that even at pre-revenue stages, legal coca processing businesses command premium venture-scale valuations [Page 10].\n\n#### Liquidity Path / Exit Strategy\n* **Planned Public Listing**: Harbour has established a near-term pathway to liquidity via a planned **Reverse Takeover (RTO)** scheduled for **Q1 2024** [Page 3].",
"schema_name": "strategy_and_portfolio",
"structured_data": {
"analystSummary": "Harbour Solutions Importation Inc. positions itself as a first-mover by establishing the first authorized Canadian channel to import and process legal Peruvian coca leaves, effectively breaking a long-standing U.S. monopoly. Leveraging an exclusive, state-sanctioned five-year supply agreement with Peru's ENACO, the company separates raw leaves into high-margin pharmaceutical alkaloids and decocainized flavoring extracts for global consumer brands. Backed by key Canadian regulatory relationships and municipal support, the company operates a capital-light, partner-driven model designed to capture substantial share across multi-billion dollar verticals ahead of its planned Q1 2024 public listing.",
"assetClass": "Private Equity",
"capitalRecycling": "Not specified",
"coInvestmentRights": "Not specified",
"concentrationLimits": "Not specified",
"dealSourcingStrategy": "Securing a historic, legally binding, exclusive 5-year trade agreement with ENACO (Empresa Nacional de la Coca), the Peruvian state-run corporation which controls the oldest and largest legal source of coca leaves globally [Page 3, Page 13, Page 14].",
"illustrativeScenarios": [],
"investmentThesis": "The core investment thesis relies on extracting and separating the coca leaf's compounds into two highly valuable revenue streams: Active Compounds (Alkaloids) sold directly to authorized pharmaceutical companies for medicinal applications, and Non-Active Compounds (Decocainized Extracts) used as flavorings and bio-functional ingredients in global consumer packaged goods (CPG) with zero psychoactive effects [Page 5, Page 19, Page 23].",
"keyClaims": [
"Secured a historic, legally binding 5-year exclusive trade agreement with Peru's ENACO, backed by over 35,000 registered local coca leaf farmers [Page 3, Page 14].",
"Positioned as the first Canadian source of legal coca leaves and derivative products, dismantling a long-standing U.S. monopoly held by Stepan Company [Page 3, Page 10, Page 11].",
"Targets a $344 billion global pharmaceutical market and a $1.0 trillion+ global consumer goods market [Page 3, Page 5].",
"Active Pharmaceutical Ingredients (APIs) are projected to deliver a 20x ROI, while Decocainized Extracts operate at a ~80% gross margin [Page 3].",
"Formally supported by the municipal government of Brampton, Ontario, providing an endorsement to build a processing facility and global headquarters in a key logistics hub [Page 12, Page 22].",
"Partnered with top-tier legal team Gowling WLG to navigate complex sovereign-level compliance, pharma, biotech, and mergers & acquisitions [Page 21]."
],
"leadInvestorStatus": "Other",
"leverageLimits": "Not specified",
"modelAssumptions": [
"Active Pharmaceutical Ingredients (APIs) deliver a 20x ROI [Page 3]",
"Decocainized Extracts operate at a ~80% gross margin [Page 3]",
"Organic Fertilizers operate at a ~50% to 60% gross margin [Page 3]"
],
"primaryObjective": "Disrupting monopolistic multi-billion dollar markets by introducing competition to a space previously monopolized by a single U.S.-based entity, Stepan Company [Page 3, Page 10].",
"qualitativeThemes": [
"Market Disruption",
"Regulatory Exclusivity & Compliance",
"Capital-Light Scale",
"Sovereign Strategic Partnerships"
],
"targetGeographies": [
"Canada",
"Peru"
],
"targetReturns": {
"cashYield": {
"is_applicable": false,
"not_applicable_reason": "Not specified for this corporate equity investment opportunity"
},
"grossIrr": {
"is_applicable": false,
"not_applicable_reason": "Not specified for this corporate equity investment opportunity"
},
"grossMoic": {
"is_applicable": true,
"not_applicable_reason": "Not specified for this corporate equity investment opportunity in aggregate, though specific segment ROI is modeled [Page 3]. Only individual product ROI is provided, not fund-level MOIC."
},
"netIrr": {
"is_applicable": false,
"not_applicable_reason": "Not specified for this corporate equity investment opportunity"
},
"netMoic": {
"is_applicable": false,
"not_applicable_reason": "Not specified for this corporate equity investment opportunity"
}
},
"targetSectors": [
"Pharmaceuticals",
"Consumer Packaged Goods (CPG)",
"Nutraceuticals",
"Functional Beverages",
"Cosmetics",
"Organic Fertilizers"
],
"targetStages": [
"Growth Equity",
"Pre-IPO"
],
"valueCreationPlaybook": [
"Importing raw leaves from ENACO under strict government regulations, executing secure transit, and processing them in a certified Canadian facility [Page 23].",
"Separating raw leaves into an Alkaloid Rich Extract (for pharmaceuticals) and an Alkaloid Free Extract (for commercial CPG applications) [Page 19, Page 23].",
"Deploying a capital-light business model through strategic manufacturing and co-packing partnerships instead of heavy capital expenditures [Page 12].",
"Leveraging formal support from the municipal government of Brampton, Ontario to build a processing facility and establish its global corporate headquarters near key logistical stakeholders [Page 12, Page 22]."
]
}
},
{
"markdown_content": "# Team and Track Record\n\n### Leadership, Operational, and Advisory Team Members\n\nThe following individuals represent the leadership, operational, and advisory teams of Harbour Solutions Importation Inc. (the \"Company\" or \"Harbour\"):\n\n* **David Craig (CEO)**\n * **Role**: Chief Executive Officer [Page 15].\n * **Investment Team Classification (`isInvestmentTeam`)**: `false`. His primary role is executive leadership and operations rather than professional investing, underwriting, or fund-level deal sourcing.\n* **Alexander Strezos (COO)**\n * **Role**: Chief Operating Officer [Page 15].\n * **Investment Team Classification (`isInvestmentTeam`)**: `false`. His primary role is operational execution and management.\n* **Setti Coscarella (VP Corporate Strategy)**\n * **Role**: Vice President of Corporate Strategy [Page 15].\n * **Investment Team Classification (`isInvestmentTeam`)**: `false`. His primary role focuses on corporate strategy rather than active investment/underwriting.\n* **Gianpaolo Caporiccio (Advisor)**\n * **Role**: Advisor [Page 15].\n * **Investment Team Classification (`isInvestmentTeam`)**: `false`. Actively advises the leadership team but is not a professional investor or underwriter for a GP.\n* **Harpreet Hansra (Political Liaison, Canada)**\n * **Role**: Political Liaison, Canada [Page 15].\n * **Investment Team Classification (`isInvestmentTeam`)**: `false`. Role is specialized in political relations and regulatory liaison within Canada.\n* **Alvaro Concha (VP Corporate Development; Latin America)**\n * **Role**: VP Corporate Development; Latin America [Page 15].\n * **Key Background Details**: Former Colombia Trade Commissioner to Canada [Page 15].\n * **Investment Team Classification (`isInvestmentTeam`)**: `false`. Focused on corporate business development and regional expansion in Latin America.\n* **Peter E. Simeon (Partner at Gowling WLG; Legal Advisor)**\n * **Role**: Legal Advisor / Partner at Gowling WLG [Page 15].\n * **Investment Team Classification (`isInvestmentTeam`)**: `false`. Provides external legal counsel and compliance support.\n\n---\n\n### Corporate Capabilities, Track Record, and Achievements\n\nWhile Harbour is an operating company (rather than a traditional General Partner managing private equity or venture capital funds), the deck highlights the operational track record of its management, advisors, and corporate partnerships:\n\n* **Executive Track Record & Industry Experience**: \n * The team possesses over 50 years of collective experience across regulatory frameworks, consumer packaged goods (CPG), capital markets, and public market environments [Page 3].\n * C-level executives on the team have previously run corporations valued at more than $600 million [Page 3].\n * **John Celenza (Co-Founder of Bio Steel)** is highlighted as part of this seasoned advisory network, having built Bio Steel (a beverage brand) and successfully grown its revenues to over $140 million [Page 3].\n* **Regulatory & Operational Licensing Success**:\n * The operations team has a proven track record in securing cultivation and processing licenses from Health Canada within highly regulated substance markets, specifically cannabis [Page 15].\n * This pharmaceutical background in processing operations is utilized to enable safe, compliant, and high-margin conversion of raw materials into finished, decocainized products [Page 15].\n* **Key Corporate Milestones**:\n * **Historic Trade Agreement**: Secured and signed a long-term international supply agreement (5 years with auto-renewal) with Enaco, the Peruvian state-run coca leaf corporation, which was later ratified by the Peruvian Congress [Page 3, Page 12, Page 14]. This agreement supports over 35,000 registered local coca leaf farmers within Peru [Page 3, Page 14] and includes negotiated preferential pricing for all coca leaf and derivative products [Page 14].\n * **First-of-its-Kind Importation**: Successfully legally imported decocainized coca leaf extract into North America (specifically Canada) for commercialization for the first time [Page 3, Page 12].\n * **Municipal Support**: Obtained local municipal support (from Mayor Patrick Brown of Brampton, Ontario, via a Letter of Support dated April 19, 2023) to build a major processing facility and global corporate headquarters [Page 12, Page 22].\n * **Public Listing Path**: Harbour has planned a public listing via a Reverse Takeover (RTO) for Q1 2024 [Page 3].\n\n---\n\n### Comparables & Industry Case Studies\n\nThe pitch deck details two primary corporate comparables in the coca leaf processing and extraction space to illustrate the market opportunity, business model feasibility, and valuations:\n\n#### 1. Stepan\n* **Location / Ownership**: US-owned, based in New Jersey and New York [Page 10].\n* **Financial Metrics**: Generates $2.2 billion in annual revenue [Page 10].\n* **Operating Model & Thesis**: \n * Currently serves as the sole existing source of coca leaf extracts and active compound derivatives sold in Canada [Page 10].\n * Imports raw coca leaves directly from Peru [Page 10].\n * Acts as the primary supplier of flavor extracts (with active compounds/alkaloids removed) to Coca-Cola [Page 10].\n * Sells the isolated active compounds (alkaloids) to Mallinckrodt, a pharmaceutical firm that generated $3.2 billion in revenue in 2019, strictly for medicinal use [Page 10].\n* **Relevance to Harbour**: Toppling the monopoly held by Stepan is a core pillar of Harbour's strategy, which positions Harbour as the first Canadian-based source for these same materials [Page 11, Page 20].\n\n#### 2. Power Leaves Corp.\n* **Location / Ownership**: Based in Neiva, South Central Colombia [Page 10].\n* **Financial Metrics & Valuation**: Pre-revenue, with a current valuation of $100 million [Page 10].\n* **Operating Model & Thesis**:\n * Operates as a processor of Colombian coca leaves [Page 10].\n * Plans to supply international customers with food and beverage extracts that have had active compounds (alkaloids) removed [Page 10].",
"schema_name": "team_and_track_record",
"structured_data": {
"additionalTeamMembers": [
{
"firstName": "Harpreet",
"lastName": "Hansra",
"title": "Political Liaison, Canada"
}
],
"advisorsAndOperatingPartners": [
{
"firstName": "Gianpaolo",
"lastName": "Caporiccio",
"title": "Advisor"
},
{
"firstName": "Peter E.",
"lastName": "Simeon",
"title": "Legal Advisor / Partner at Gowling WLG"
},
{
"firstName": "John",
"lastName": "Celenza",
"title": "Advisor"
}
],
"caseStudies": [
{
"companyName": "Stepan"
},
{
"companyName": "Power Leaves Corp.",
"currentOrExitValuation": {
"currency": "USD",
"exact_amount": {
"amount": 100,
"magnitude": "MILLIONS"
},
"normalized_exact_amount": 100000000,
"source_number_text": "$100 million",
"unit": "MONETARY"
}
}
],
"firmLeadership": [
{
"firstName": "David",
"lastName": "Craig",
"title": "Chief Executive Officer"
},
{
"firstName": "Alexander",
"lastName": "Strezos",
"title": "Chief Operating Officer"
},
{
"firstName": "Setti",
"lastName": "Coscarella",
"title": "Vice President of Corporate Strategy"
},
{
"firstName": "Alvaro",
"lastName": "Concha",
"title": "VP Corporate Development; Latin America"
}
],
"keyPrincipals": [],
"performanceAsOfDate": "Not specified",
"priorVehicles": []
}
},
{
"markdown_content": "# Warehoused Deals\n\nBased on the Harbour pitch deck, the company is presented as an operating entity seeking a public listing via Reverse Takeover (RTO) in Q1 2024 rather than a traditional multi-asset investment fund [Slide 3]. Consequently, traditional \"warehoused deals\" in the form of fund-seeded investment assets do not apply directly. However, the company has secured several foundational \"seed\" assets, exclusive supply agreements, proprietary product pipelines, and facility options that represent the core asset base being brought to public markets:\n\n### 1. Exclusive & Secured Raw Material Supply Agreements\n* **Historic Enaco Partnership:** Harbour has secured a historic partnership with Enaco (Empresa Nacional de la Coca), the Peruvian state-run coca leaf production company [Slide 3, Slide 13]. \n* **Long-Term Supply Certainty:** This consists of an officially signed, long-term international supply agreement with a 5-year duration featuring auto-renewal [Slide 14].\n* **Scale of Supply network:** The agreement legally supports and provides access to over 35,000 registered local coca leaf farmers in the Enaco network in Peru [Slide 3, Slide 14].\n* **Preferential Terms:** Harbour has negotiated preferential pricing for all coca leaf and coca leaf derivative products with Enaco [Slide 14]. This secures a consistent and expanding supply exported directly from Peru and imported into Canada [Slide 13].\n* **Proof-of-Concept Seed Importation:** Harbour has already successfully and legally imported decocainized coca leaf extract into Canada/North America for the first time, establishing the operational pathway [Slide 3, Slide 12].\n\n### 2. Proprietary In-House Brand & Product Pipeline (The Launch Portfolio)\nBefore transitioning to commercializing ingredients for external Consumer Packaged Goods (CPG) brands, Harbour is seeding its commercial operations with its own suite of proprietary brands [Slide 3]:\n* **Ratio (Brand):** A proprietary brand focused on performance and health, starting with \"Pure Plant Protein\" (a plant-based protein powder delivering 20g of protein and 100 calories per serving) [Slide 29, Slide 34].\n* **Constitution Nutraceuticals (Brand):** A proprietary brand launching \"Whole Body Vitality\" chewable tablets, which are plant-based dietary supplements utilizing coca leaf extract [Slide 30, Slide 34, Slide 35].\n* **Harbour Nootropic Beverages (Brand):** A proprietary brand of functional beverages [Slide 31]. The product line includes distinct SKUs such as:\n * \"ZZZZZ\" (coca leaf, damiana, and sarsaparilla active ingredients) [Slide 31, Slide 32, Slide 33]\n * \"Rough Night\" [Slide 32, Slide 33]\n * \"Hunker Down\" [Slide 32, Slide 33]\n * \"Mirror Mirror\" [Slide 32, Slide 33]\n * \"Super Excellent\" [Slide 32, Slide 33]\n * \"Get Some\" [Slide 32]\n * \"Warm Blanket\" [Slide 32]\n* **Launch Roadmap:** The initial launch portfolio consists of four primary internal products: an energy drink beverage, a lifestyle coca-infused water, a single-serve protein powder, and an energy shot [Slide 3].\n\n### 3. Pre-Identified Commercial & Distribution Pipeline\n* **CPG Brands Pipeline:** Harbour is in active, current discussions with several established CPG brands across North America to supply non-active coca leaf extracts [Slide 3].\n* **Distribution Contracts:** Distribution contracts for Harbour's in-house suite of brands (Ratio, Constitution, and Nootropic Beverages) are currently in the final stages of negotiation [Slide 3].\n* **Target Commercial Verticals:** The company has pre-identified and targeted key commercial customers across active pharmaceutical ingredients (APIs) and non-active extracts [Slide 23]:\n * **Active Compounds (Alkaloids):** Target pipeline pharmaceutical customers under independent Health Canada approved licenses include Sun Pharma, Apotex, GSK, and Taro [Slide 23].\n * **Non-Active Extracts:** Target pipeline commercial partners for flavor and consumer goods include Coca-Cola, Cott (for Walmart), Red Bull, Aesop, Tom Ford, and LUSH [Slide 23].\n\n### 4. Seeded Infrastructure & Real Estate Pipelines\n* **Brampton processing Facility Option:** Harbour has secured formal municipal support from Mayor Patrick Brown of Brampton, Ontario, to build its major processing facility and global corporate headquarters in the city of Brampton [Slide 22].\n* **Strategic Collocation:** The pre-identified facility location in Brampton is chosen for its proximity to key future stakeholders and logistics hubs, including Coca-Cola and Sun Pharmaceuticals [Slide 22].\n* **Academic/R&D Pipeline:** Harbour has developed plans to build a research arm to support co-op programs with Toronto Metropolitan University’s School of Medicine and Sheridan College [Slide 22].",
"schema_name": "warehoused_deals",
"structured_data": {
"pipelineCompanies": [
{
"coInvestors": [],
"companyName": "Enaco",
"description": "Empresa Nacional de la Coca, the Peruvian state-run coca leaf production company with an officially signed 5-year long-term international supply agreement with auto-renewal.",
"headquarters": "Peru",
"sector": "Agriculture",
"source": "Proprietary",
"status": "Closed"
}
]
}
}
],
"fileKey": "decks/2a09b8bbbbedd6c5339ae9619ec9ac9704f1ab7f6e2a840357a88b1146389363.pdf",
"file_search_stores": [
{
"active_documents_count": 0,
"fund_id": "12",
"run_id": "27",
"store_name": "fileSearchStores/dealsworkflowproductionunkn-8pkhahz0gtyw",
"topic": "all"
}
],
"fund_entity": {
"master_data": {
"base_currency": "USD",
"classification": {
"asset_class": "Private Equity",
"primary_strategy": null,
"sub_asset_class": null
},
"economics": {
"carried_interest_pct": null,
"catch_up_pct": null,
"gp_commitment_pct": null,
"hurdle_rate_pct": null,
"management_fee_basis": null,
"management_fee_pct": null,
"waterfall_type": null
},
"firm_name": null,
"fund_name": null,
"fundraising_and_governance": {
"auditor": null,
"fund_administrator": null,
"legal_counsel": null
},
"performance_and_returns": {
"dpi": null,
"gross_moic": null,
"realized_net_irr_pct": null,
"target_moic": null,
"target_net_irr_pct": null,
"tvpi": null
},
"portfolio_construction": {
"follow_on_reserve_pct": null,
"initial_check_size_max_usd": null,
"initial_check_size_min_usd": null,
"lead_investor_status": null,
"target_number_of_investments_max": null,
"target_number_of_investments_min": null,
"target_ownership_pct": null
},
"scale_and_lifecycle": {
"fund_sequence": null,
"hard_cap": null,
"investment_period_months": null,
"minimum_ticket_size": null,
"target_fund_size": null,
"target_fund_size_usd": null,
"term_duration_months": null,
"vintage_year": null
},
"sourcing_and_underwriting": {
"credit_committee_approval_process": null,
"sourcing_channels": [],
"underwriting_timeline_months": null
},
"strategy_and_focus": {
"capital_stack_position": [],
"domicile": null,
"economic_drivers": [],
"geography": {
"regions": []
},
"key_risks": [],
"methods_of_investment": [],
"sector_focus": []
},
"value_creation": {
"dedicated_operating_partners": null,
"ebitda_margin_expansion_target": null,
"m_and_a_strategy": null,
"operational_levers": []
}
},
"name": "Harbour IR Deck Nov2023 2 (1)",
"possible_fund_name": [
{
"name": "Harbour Solutions Importation Inc. Fund Series I",
"rationale": "Derived from the combination of the management company name and the specific fund series mentioned in the fund_overview_and_terms."
}
],
"strategy": {},
"warehoused_deals": {
"pipelineCompanies": [
{
"coInvestors": [],
"companyName": "Enaco",
"description": "Empresa Nacional de la Coca, the Peruvian state-run coca leaf production company with an officially signed 5-year long-term international supply agreement with auto-renewal.",
"headquarters": "Peru",
"sector": "Agriculture",
"source": "Proprietary",
"status": "Closed"
}
]
}
},
"gemini_store_files": [
{
"description": "Synced PDF Pitch Deck (Pitch Deck PDF - Harbour_IR_Deck_Nov2023 2 (1)) to Gemini.",
"developer_name": "unknown",
"display_name": "Pitch Deck PDF - Harbour_IR_Deck_Nov2023 2 (1)",
"environment": "production",
"expiration_time": "2026-07-24T18:19:12.389171935Z",
"external_id": "decks/2a09b8bbbbedd6c5339ae9619ec9ac9704f1ab7f6e2a840357a88b1146389363.pdf",
"file_extension": "pdf",
"file_size": 44489687,
"gemini_file_id": "files/muny8y0j7sq7",
"mime_type": "application/pdf",
"run_id": "27",
"sha256": "2a09b8bbbbedd6c5339ae9619ec9ac9704f1ab7f6e2a840357a88b1146389363",
"state": "ACTIVE",
"store_name": "fileSearchStores/dealsworkflowproductionunkn-9mk1fx9u1kxz",
"system": "trigger",
"task_name": "sync-file-to-gemini",
"uri": "https://generativelanguage.googleapis.com/v1beta/files/muny8y0j7sq7"
},
{
"content": "{\n \"fundName\": \"Harbour Solutions Importation Inc.\",\n \"managementCompany\": \"Harbour Solutions Importation Inc.\",\n \"fundSeries\": \"I\",\n \"vintageYear\": \"2024\",\n \"primaryAssetClass\": \"Unknown\",\n \"isOpenEnded\": false,\n \"classificationReasoning\": \"The provided presentation represents a corporate investment opportunity in an operating company rather than a traditional private equity, venture capital, or real estate fund.\",\n \"managerClassification\": \"Established\",\n \"maturityClassificationReasoning\": \"The management team has over 50 years of cumulative experience, with key executives having experience running corporations valued at $600 million+.\",\n \"isFirstTimeFund\": true,\n \"diversityClaims\": [],\n \"attributedTrackRecord\": \"John Celenza scaled Bio Steel to over $140 million in revenue, and key executives have run corporations valued at $600 million+.\",\n \"domicile\": \"Canada\",\n \"regulatoryExemptions\": [],\n \"keyRiskDisclosures\": [\n \"Speculative Nature\",\n \"Lack of Liquidity\",\n \"Capital Requirements\",\n \"Regulatory and Licensing Risks\",\n \"Legal Uncertainty\",\n \"Banking and Financial Services Access\",\n \"Insurance Risks\",\n \"Third-Party Reliance\",\n \"Public and Legislative Acceptance\"\n ]\n}",
"description": "Human-readable Markdown/RAG optimized response generated for Harbour Solutions Importation Inc. by the Pitch_deck_schema_fund_overview_and_terms task.",
"developer_name": "unknown",
"display_name": "Pitch Deck Extractions - fund_overview_and_terms Research Report",
"environment": "production",
"evaluation_metadata": {
"belongs_to": "Harbour Solutions Importation Inc.",
"content_sha": "b942153d275c2aeafc877f163a876a45486f674d0d4d938ebf44cd2974980e59",
"data_type": "processed_output",
"deep_research_tool": "jina",
"document_group": "fund",
"entity_type": "fund",
"fund_id": "12",
"is_deep_research": true,
"is_research": true,
"origin": "deep_research_pipeline",
"run_id": "27",
"task_identifier": "pitch_deck_schema_fund_overview_and_terms",
"task_name": "pitch_deck_schema_fund_overview_and_terms",
"topic": "fund_harbour_ir_deck_nov2023_2__1_"
},
"expiration_time": "2026-07-24T18:28:47.778905547Z",
"file_extension": "md",
"file_size": 6746,
"gemini_create_time": "2026-07-22T18:28:48.059758Z",
"gemini_file_id": "files/rheahcmohzr8",
"gemini_update_time": "2026-07-22T18:28:48.059758Z",
"markdown_content": "# Pitch_deck_schema_fund_overview_and_terms Response\n\n## Technical Context\n- **Task Name**: pitch_deck_schema_fund_overview_and_terms\n- **Workflow Run ID**: 27\n- **Timestamp**: 2026-07-22T18:28:47.106Z\n\n## Grounded Intelligence Data\n# fund_overview_and_terms\n\n### Executive Summary & Note on Entity Structure\nThe provided presentation represents a corporate investment opportunity in an operating company rather than a traditional private equity, venture capital, or real estate fund. Consequently, the terms, structure, and risk management criteria below reflect the corporate organization, regulatory classification, and pathway to liquidity for **Harbour Solutions Importation Inc.**, serving as the functional equivalent of a fund's structural terms [Page 2].\n\n---\n\n### Corporate Identity & Management Company\n* **Formal Entity Name:** Harbour Solutions Importation Inc. (referred to as \"the Company\" or \"Harbour\") [Page 2].\n* **Headquarters & Domicile:** Headquartered and domiciled in Canada [Page 3, Page 12].\n* **Management Maturity & Experience:** \n * Described as \"Seasoned executive management and advisory\" with over 50 years of cumulative regulatory, CPG, capital, and public market experience [Page 3].\n * Key executives have experience running corporations valued at $600 million+ [Page 3]. \n * Notable leadership includes John Celenza, Co-Founder of Bio Steel, who previously scaled that brand to over $140 million in revenue [Page 3].\n * The operations team has a track record of successfully securing cultivation and processing licenses from Health Canada in regulated substance markets (specifically Cannabis) [Page 15].\n\n---\n\n### Investment Strategy & Offering Terms\n* **Asset Class / Industry Focus:** Agriculture, Biotechnology, Pharmaceuticals, and Consumer Packaged Goods (CPG) focused on the legal importation, processing, and distribution of the *Erythroxylum coca* (coca plant) and its active/non-active derivatives [Page 1, Page 5].\n* **Business & Capital Deployment Model:** \n * \"Capital light business model\" wherein Harbour deploys capital to build revenue through strategic partnerships rather than committing to major capital expenditures [Page 12].\n * The supplier serves as a manufacturer, providing a short path to commercialization via immediate co-packing options [Page 3].\n* **Target Verticals & Market Size:**\n * **Active Pharmaceutical Ingredients (APIs):** Target addressable pharmaceutical market size of $344 billion (including Diet & Weight Loss at $175.2B, ADHD Medication at $32.24B, Local Anesthetics at $2.6B, Anti-Inflammatory Medications at $111.42B, and Vasoconstriction in Capillaries at $6B) [Page 3, Page 5].\n * **Consumer Goods (Non-Active Compounds):** Target addressable market of $1 Trillion+ (including Energy Drinks at $53.1B, Global Functional Foods at $305.4B, Nutraceuticals at $423B, and Beauty & Personal Care at $579B) [Page 3, Page 5].\n * **Commercial Fertilizer:** Target addressable market of $268 billion [Page 5] (elsewhere referenced as a $200 billion market [Page 3, Page 18]).\n* **Pathway to Liquidity (Fund Life / Horizon Equivalent):** \n * The Company has a public listing planned via a Reverse Takeover (RTO) scheduled for Q1 2024 [Page 3].\n\n---\n\n### Key Legal, Regulatory, and Government Entities\n* **Legal Advisor:** Gowling WLG, which provides legal representation, assists in navigating compliance requirements, and facilitates strategic value chain partnerships [Page 15, Page 21]. Peter E. Simeon is named as Partner at Gowling WLG and Legal Advisor to Harbour [Page 15].\n* **Regulatory Oversight Bodies:** Harbour collaborates and maintains ongoing regulatory discussions with:\n * Health Canada [Page 12, Page 15, Page 23]\n * Canadian Food Inspection Agency (CFIA) [Page 12]\n * Royal Canadian Mounted Police (RCMP-GRC) [Page 12]\n * Canada Border Services Agency (CBSA) [Page 12]\n* **Strategic Supply Partner:** ENACO (*Empresa Nacional de la Coca*), the Peruvian state-run coca leaf corporation [Page 13, Page 14]. \n * Harbour has officially signed a 5-year international supply agreement with ENACO featuring an automatic renewal clause [Page 14].\n * The agreement includes negotiated \"preferential pricing\" for all coca leaves and coca leaf derivative products [Page 14].\n * ENACO represents a network of over 35,000 registered local coca leaf farmers in Peru [Page 3, Page 14].\n* **Municipal Government Partner:** City of Brampton, Ontario, Canada [Page 22].\n * Brampton Mayor Patrick Brown issued a formal Letter of Support dated April 19, 2023, endorsing Harbour's intention to establish its major processing facility and global corporate headquarters in the municipality [Page 22].\n\n---\n\n### Regulatory Exemptions & Operational Status\n* **Exemptions & First-Mover Status:** \n * Successfully legally imported decocainized coca leaf extract into Canada/North America for commercialization [Page 3, Page 12].\n * Positioned as the first Canadian source of coca leaves and their derivative products, challenging the existing US monopoly held by Stepan [Page 10, Page 11, Page 20].\n * Operational framework is aligned with the Canadian government's ongoing investigation into alternative frameworks to prevent harm caused by opioids (\"Safe Supply\" initiatives) [Page 3, Page 24].\n\n---\n\n### Explicit Risk Disclosures for Investors\nAccording to the formal Legal Disclaimer, potential investors are subject to the following key risks [Page 2]:\n* **Speculative Nature:** Investments in the Company are speculative and carry no guarantee of performance or returns [Page 2].\n* **Lack of Liquidity:** There is currently no liquid market for the Company's securities [Page 2].\n* **Capital Requirements:** The Company requires additional funding to execute its business strategies [Page 2].\n* **Regulatory and Licensing Risks:** The business is highly dependent on securing, maintaining, and complying with required licenses, permits, and authorizations from various levels of government [Page 2].\n* **Legal Uncertainty:** Risks associated with changes in local or international laws, or the non-occurrence of anticipated legal/policy changes [Page 2].\n* **Banking and Financial Services Access:** Risks of potential denial of banking services due to the specific regulatory nature of the industry in which the Company operates [Page 2].\n* **Insurance Risks:** Risks related to the denial of insurance coverage or the inability to obtain insurance coverage at reasonable rates [Page 2].\n* **Third-Party Reliance:** Heavy operational reliance on third-party suppliers and partners (such as ENACO) [Page 2, Page 13].\n* **Public and Legislative Acceptance:** Operational success is subject to acceptance by the general public and legislators [Page 2].\n",
"mime_type": "text/markdown",
"run_id": "27",
"sha256": "ZDBhYjJmMmQwODczZjhhMDZlOGZlNDI3ZmFiODQ0ODNhZThiMWM2YzNmNGQ4Zjc1ZTgyYWFkMzUwMDY2NDdkOA==",
"state": "ACTIVE",
"store_name": "fileSearchStores/dealsworkflowproductionunkn-vknhwxca4dwr",
"system": "trigger",
"task_name": "pitch_deck_schema_fund_overview_and_terms",
"uri": "https://generativelanguage.googleapis.com/v1beta/files/rheahcmohzr8"
},
{
"content": "{\n \"assetClass\": \"Private Equity\",\n \"targetStages\": [\n \"Growth Equity\",\n \"Pre-IPO\"\n ],\n \"targetSectors\": [\n \"Pharmaceuticals\",\n \"Consumer Packaged Goods (CPG)\",\n \"Nutraceuticals\",\n \"Functional Beverages\",\n \"Cosmetics\",\n \"Organic Fertilizers\"\n ],\n \"targetGeographies\": [\n \"Canada\",\n \"Peru\"\n ],\n \"primaryObjective\": \"Disrupting monopolistic multi-billion dollar markets by introducing competition to a space previously monopolized by a single U.S.-based entity, Stepan Company [Page 3, Page 10].\",\n \"investmentThesis\": \"The core investment thesis relies on extracting and separating the coca leaf's compounds into two highly valuable revenue streams: Active Compounds (Alkaloids) sold directly to authorized pharmaceutical companies for medicinal applications, and Non-Active Compounds (Decocainized Extracts) used as flavorings and bio-functional ingredients in global consumer packaged goods (CPG) with zero psychoactive effects [Page 5, Page 19, Page 23].\",\n \"valueCreationPlaybook\": [\n \"Importing raw leaves from ENACO under strict government regulations, executing secure transit, and processing them in a certified Canadian facility [Page 23].\",\n \"Separating raw leaves into an Alkaloid Rich Extract (for pharmaceuticals) and an Alkaloid Free Extract (for commercial CPG applications) [Page 19, Page 23].\",\n \"Deploying a capital-light business model through strategic manufacturing and co-packing partnerships instead of heavy capital expenditures [Page 12].\",\n \"Leveraging formal support from the municipal government of Brampton, Ontario to build a processing facility and establish its global corporate headquarters near key logistical stakeholders [Page 12, Page 22].\"\n ],\n \"dealSourcingStrategy\": \"Securing a historic, legally binding, exclusive 5-year trade agreement with ENACO (Empresa Nacional de la Coca), the Peruvian state-run corporation which controls the oldest and largest legal source of coca leaves globally [Page 3, Page 13, Page 14].\",\n \"qualitativeThemes\": [\n \"Market Disruption\",\n \"Regulatory Exclusivity & Compliance\",\n \"Capital-Light Scale\",\n \"Sovereign Strategic Partnerships\"\n ],\n \"analystSummary\": \"Harbour Solutions Importation Inc. positions itself as a first-mover by establishing the first authorized Canadian channel to import and process legal Peruvian coca leaves, effectively breaking a long-standing U.S. monopoly. Leveraging an exclusive, state-sanctioned five-year supply agreement with Peru's ENACO, the company separates raw leaves into high-margin pharmaceutical alkaloids and decocainized flavoring extracts for global consumer brands. Backed by key Canadian regulatory relationships and municipal support, the company operates a capital-light, partner-driven model designed to capture substantial share across multi-billion dollar verticals ahead of its planned Q1 2024 public listing.\",\n \"keyClaims\": [\n \"Secured a historic, legally binding 5-year exclusive trade agreement with Peru's ENACO, backed by over 35,000 registered local coca leaf farmers [Page 3, Page 14].\",\n \"Positioned as the first Canadian source of legal coca leaves and derivative products, dismantling a long-standing U.S. monopoly held by Stepan Company [Page 3, Page 10, Page 11].\",\n \"Targets a $344 billion global pharmaceutical market and a $1.0 trillion+ global consumer goods market [Page 3, Page 5].\",\n \"Active Pharmaceutical Ingredients (APIs) are projected to deliver a 20x ROI, while Decocainized Extracts operate at a ~80% gross margin [Page 3].\",\n \"Formally supported by the municipal government of Brampton, Ontario, providing an endorsement to build a processing facility and global headquarters in a key logistics hub [Page 12, Page 22].\",\n \"Partnered with top-tier legal team Gowling WLG to navigate complex sovereign-level compliance, pharma, biotech, and mergers & acquisitions [Page 21].\"\n ],\n \"leadInvestorStatus\": \"Other\",\n \"concentrationLimits\": \"Not specified\",\n \"leverageLimits\": \"Not specified\",\n \"coInvestmentRights\": \"Not specified\",\n \"capitalRecycling\": \"Not specified\",\n \"targetReturns\": {\n \"grossIrr\": {\n \"is_applicable\": false,\n \"not_applicable_reason\": \"Not specified for this corporate equity investment opportunity\"\n },\n \"netIrr\": {\n \"is_applicable\": false,\n \"not_applicable_reason\": \"Not specified for this corporate equity investment opportunity\"\n },\n \"grossMoic\": {\n \"is_applicable\": true,\n \"not_applicable_reason\": \"Not specified for this corporate equity investment opportunity in aggregate, though specific segment ROI is modeled [Page 3]. Only individual product ROI is provided, not fund-level MOIC.\"\n },\n \"netMoic\": {\n \"is_applicable\": false,\n \"not_applicable_reason\": \"Not specified for this corporate equity investment opportunity\"\n },\n \"cashYield\": {\n \"is_applicable\": false,\n \"not_applicable_reason\": \"Not specified for this corporate equity investment opportunity\"\n }\n },\n \"illustrativeScenarios\": [],\n \"modelAssumptions\": [\n \"Active Pharmaceutical Ingredients (APIs) deliver a 20x ROI [Page 3]\",\n \"Decocainized Extracts operate at a ~80% gross margin [Page 3]\",\n \"Organic Fertilizers operate at a ~50% to 60% gross margin [Page 3]\"\n ]\n}",
"description": "Human-readable Markdown/RAG optimized response generated by the Pitch_deck_schema_strategy_and_portfolio task.",
"developer_name": "unknown",
"display_name": "Pitch Deck Extractions - strategy_and_portfolio Research Report",
"environment": "production",
"evaluation_metadata": {
"content_sha": "b9a0bb1d208a149ce22b6b0e27a27fecfff080348a6044dda8ddcb1df2f28e4e",
"data_type": "processed_output",
"deep_research_tool": "jina",
"document_group": "fund",
"entity_type": "fund",
"fund_id": "12",
"is_deep_research": true,
"is_research": true,
"origin": "deep_research_pipeline",
"run_id": "27",
"task_identifier": "pitch_deck_schema_strategy_and_portfolio",
"task_name": "pitch_deck_schema_strategy_and_portfolio",
"topic": "fund_harbour_ir_deck_nov2023_2__1_"
},
"expiration_time": "2026-07-24T18:28:57.635624553Z",
"file_extension": "md",
"file_size": 12713,
"gemini_create_time": "2026-07-22T18:28:57.817543Z",
"gemini_file_id": "files/z9b9k9ujhsqu",
"gemini_update_time": "2026-07-22T18:28:57.817543Z",
"markdown_content": "# Pitch_deck_schema_strategy_and_portfolio Response\n\n## Technical Context\n- **Task Name**: pitch_deck_schema_strategy_and_portfolio\n- **Workflow Run ID**: 27\n- **Timestamp**: 2026-07-22T18:28:56.914Z\n\n## Grounded Intelligence Data\n# Strategy and Portfolio\n\n### Executive Analyst Summary\nHarbour Solutions Importation Inc. positioning as the first authorized Canadian importer and processor of legal Peruvian coca leaves presents a highly lucrative, first-mover opportunity to dismantle a long-standing U.S. monopoly in the multi-billion dollar active and non-active compound markets. By securing a historic, exclusive five-year state-sanctioned supply agreement with Peru's ENACO, Harbour mitigates critical regulatory barriers and establishes a capital-light, high-margin business model designed to supply both the $344 billion pharmaceutical API sector and the $1 trillion+ consumer packaged goods market. Backed by experienced municipal, political, and regulatory leaders, the company is poised to capture significant market share across multiple verticals, including functional beverages, cosmetics, nutraceuticals, and organic fertilizers, ahead of a planned public listing. [Page 1, Page 2, Page 3, Page 10, Page 11, Page 12]\n\n---\n\n### Core Qualitative Narrative and Investment Thesis\n\n#### Primary Investment Objective & Thesis\n* **Disrupting Monopolistic Multi-Billion Dollar Markets**: Harbour aims to capitalize on a \"once-in-a-generation\" market opportunity by introducing competition to a space previously monopolized by a single U.S.-based entity, Stepan Company [Page 3, Page 10]. \n* **The \"First-Mover\" Advantage in Canada**: Harbour is positioned as the first Canadian source of coca leaves and their derivative products [Page 11]. This enables Canadian and international brands to tap into the therapeutic and flavor profiles of the coca plant legally in North America [Page 8, Page 11].\n* **Active vs. Non-Active Compound Bifurcation**: The core investment thesis relies on extracting and separating the coca leaf's compounds into two highly valuable revenue streams:\n * *Active Compounds (Alkaloids)*: Sold directly to authorized pharmaceutical companies for medicinal applications [Page 5, Page 19, Page 23].\n * *Non-Active Compounds (Decocainized Extracts)*: Used as flavorings and bio-functional ingredients in global consumer packaged goods (CPG) with zero psychoactive effects [Page 5, Page 19, Page 23].\n\n#### Market Opportunities & Addressable Markets\n* **Total Addressable Pharmaceutical Market**: Valued at **$344 billion** globally (as of 2022) [Page 3, Page 5]. Specific addressable medical applications include:\n * Diet & Weight Loss: **$175.2 billion** [Page 5]\n * ADHD Medication: **$32.24 billion** [Page 5]\n * Anti-Inflammatory Medications: **$111.42 billion** [Page 5]\n * Vasoconstriction in Capillaries: **$6.0 billion** [Page 5]\n * Local Anesthetics: **$2.6 billion** [Page 5]\n* **Total Addressable Consumer Goods Market**: Valued at **$1.0 trillion+** globally (as of 2022) [Page 3, Page 5]. Specific addressable categories include:\n * Beauty & Personal Care: **$579.0 billion** [Page 5]\n * Nutraceuticals: **$382.0 billion** to **$423.0 billion** [Page 4, Page 5]\n * Global Functional Foods: **$275.0 billion** to **$305.4 billion** [Page 4, Page 5]\n * Fertilizers for Commercial Agriculture: **$200.0 billion** to **$268.0 billion** [Page 3, Page 5, Page 18]\n * Energy Drinks: **$50.0 billion** to **$53.1 billion** [Page 4, Page 5]\n\n#### Sourcing Strategies & Global Partnerships\n* **State-Sanctioned Monopolistic Partnership**: Harbour has secured a historic, legally binding trade agreement with **ENACO** (Empresa Nacional de la Coca), the Peruvian state-run corporation which controls the oldest and largest legal source of coca leaves globally [Page 3, Page 13, Page 14].\n* **Agreement Scope and Farmers Network**: The international supply agreement is a **5-year contract with automatic renewal** [Page 14]. This contract directly supports and sources from a network of over **35,000 registered local Peruvian coca leaf farmers** [Page 3, Page 14].\n* **Preferential Pricing**: Harbour has negotiated preferential, exclusive pricing structures with ENACO for all raw coca leaves and derivative products [Page 14].\n* **Ratification and Legality**: The trade agreement was fully ratified by the Peruvian Congress, assuring sovereign-level legal protection and compliance [Page 12].\n\n#### Value Creation Playbook & Operating Model\n* **The Decocainization & Extraction Loop**: The proprietary extraction process consists of importing raw leaves from ENACO under strict government regulations, executing secure transit, and processing them in a certified Canadian facility [Page 23].\n * *Step 1*: Raw leaves go into the Coca Extractor [Page 19].\n * *Step 2*: Separation into an Alkaloid Rich Extract and an Alkaloid Free Extract [Page 19].\n * *Step 3*: The Alkaloid Rich Extract yields active pharmaceutical compounds [Page 19, Page 23].\n * *Step 4*: The Alkaloid Free Extract is processed into high-margin liquid or powder extracts for commercial CPG applications [Page 19, Page 23].\n* **Capital-Light Business Model**: Instead of executing major capital expenditures, Harbour deploys its capital to generate revenue through strategic manufacturing and co-packing partnerships [Page 12].\n* **Turnkey Co-Packing Capabilities**: The Peruvian supplier also acts as a manufacturer, offering immediate co-packing opportunities that drastically shorten the traditional path to commercialization [Page 3].\n\n#### GP Competitive Edge & Barriers to Entry\n* **Regulatory Exclusivity & Compliance**: Harbour operates with full compliance under municipal, provincial, and federal regulations [Page 13]. The operations team possesses a proven track record of securing cultivation and processing licenses from **Health Canada** in complex regulated substance markets (e.g., Cannabis) [Page 15].\n* **Strong Political Currency**: Harbour has obtained significant political and law enforcement support in Canada [Page 20]. The company is actively collaborating with regulatory bodies, including Health Canada, the Canadian Food Inspection Agency (CFIA), the Royal Canadian Mounted Police (RCMP), and the Canada Border Services Agency (CBSA) [Page 12].\n* **Sovereign Legal Advisory**: Legal representation and compliance navigation are led by **Gowling WLG**, a top-tier legal team specializing in pharma, biotech, and complex mergers & acquisitions [Page 21].\n* **Municipal Infrastructure Support**: Harbour has received formal support from the municipal government of Brampton, Ontario [Page 12, Page 22]. In a Letter of Support dated April 19, 2023, Mayor Patrick Brown endorsed Harbour's plans to build a processing facility and establish its global corporate headquarters in Brampton, highlighting its role as a key logistics hub near stakeholders like Coca-Cola and Sun Pharmaceuticals [Page 22].\n\n---\n\n### Portfolio Construction Parameters & Business Model\n\n#### Three Main Verticals & Product Offerings\nHarbour builds its portfolio around three core operational verticals [Page 3]:\n\n| Vertical | Market Size | Portfolio Parameters & Core Offerings |\n| :--- | :--- | :--- |\n| **Active Pharmaceutical Ingredients (APIs)** | $344 Billion [Page 3] | • Alkaloids sold to pharmaceutical firms for prescription therapeutics.<br>• Target uses: Diet/weight loss, ADHD meds, local anesthetics, anti-inflammatories [Page 5]. |\n| **CPG Brand Ingredients & Direct Brands** | $1 Trillion+ [Page 3] | • Supplying decocainized flavorings to blue-chip global brands [Page 12, Page 16].<br>• Launching proprietary in-house brands: \"Ratio\" (Pure Plant Protein) and \"Constitution Nutraceuticals\" (Whole Body Vitality) [Page 29, Page 30, Page 34].<br>• Launching a portfolio of nootropic lifestyle beverages [Page 3, Page 31, Page 32, Page 33]. |\n| **Fertilizer Ingredients** | $200 Billion [Page 3] | • Commercial-grade organic liquid fertilizers produced locally in Canada [Page 18].<br>• Promotes higher crop yields relative to traditional nitrogen fertilizers [Page 18]. |\n\n#### Target Geographies and Regulatory Frameworks\n* **Canada as a Launchpad**: Harbour is headquartered in Canada, leveraging the country's position as one of the first G7 nations to actively explore the descheduling of controlled substances [Page 3]. \n* **Safe Supply Movement Exemption**: The city of Vancouver has already received exemptions to deschedule drugs, with proposals under consideration to expand this framework nationwide [Page 3]. Harbour is positioned to satisfy the government's need for a safe, non-organized-crime-affiliated supply chain of raw materials [Page 3].\n* **Federal Framework Alignment**: Harbour is structuring its operations to align with the Canadian government's ongoing investigation into safe frameworks to prevent harm caused by synthetic opioids [Page 24].\n\n#### Partnerships and Customer Target Architecture\nHarbour has structured its business model to target two clear segments of enterprise customers [Page 23]:\n\n```\n [Raw Coca Leaf Importation (ENACO)]\n │\n [Secure Transport Link]\n │\n [Canadian Processing Hub]\n ┌┴┐\n ┌───────────────────────────┘ └────────────────────────────┐\n ▼ ▼\n [Active Compounds (Alkaloids)] [Non-Active Extracts]\n │ │\n ┌────────┴────────┬────────┐ ┌────────┬───────┼────────┬───────┐\n ▼ ▼ ▼ ▼ ▼ ▼ ▼ ▼\n[Sun Pharma] [Apotex] [GSK] [Coca-Cola] [Cott] [Redbull] [Aesop] [Lush]\n```\n\n* **Target Pharma API Clients**: Includes Johnson & Johnson ($96.26B revenue), Bayer ($47.5B revenue), AstraZeneca ($44.35B revenue), Merck ($42.84B revenue), Pfizer ($18.28B revenue), Sun Pharma ($5.1B revenue), Apotex ($1.2B revenue), and GSK ($1.07B revenue) [Page 9, Page 23].\n* **Target Non-Active Extract Clients**: Includes Coca-Cola ($43B revenue), Redbull ($10.2B revenue), Cott Beverage/Walmart ($2B revenue), LUSH ($1.06B revenue), Tom Ford ($654M revenue), and Aesop ($537M revenue) [Page 8, Page 23].\n\n---\n\n### Financial Models & Projected Returns\n\n#### Modeled Margins and Projected Returns\nThe company's commercialized offerings are characterized by exceptionally high return-on-investment (ROI) structures and gross margin profiles at scale [Page 3]:\n* **Active Pharmaceutical Ingredients (APIs)**: Projected to deliver a **20x ROI** [Page 3].\n* **Decocainized Extracts**: Projected to operate at a **~80% gross margin** [Page 3].\n* **Organic Fertilizers**: Projected to operate at a **~50% to 60% gross margin** [Page 3].\n\n#### Key Comparables and Competitive Valuation\nHarbour's competitive analysis features two primary comparables to highlight its valuation and market potential [Page 10]:\n* **Stepan Company (US)**:\n * *Revenue & Status*: A US-owned, publicly traded company (based in New Jersey/New York) generating **$2.2 billion in annual revenue** [Page 10].\n * *Role*: Historically, the *only* legal importer of coca leaves from Peru to North America. Stepan processes the leaves, sells the flavor extracts to Coca-Cola, and sells the extracted active alkaloid compounds to Mallinckrodt (a pharmaceutical firm with $3.2 billion in 2019 revenue) for medicinal use [Page 10].\n * *Implication*: Stepan represents a direct model of Harbour's operational strategy, confirming the viability of a dual-revenue extraction business [Page 10, Page 23].\n* **Power Leaves Corp. (Colombia)**:\n * *Valuation & Status*: A Colombia-based, pre-revenue start-up valued at **$100 million** [Page 10].\n * *Role*: Processors of Colombian coca leaves with plans to export decocainized extracts internationally [Page 10].\n * *Implication*: Demonstrates that even at pre-revenue stages, legal coca processing businesses command premium venture-scale valuations [Page 10].\n\n#### Liquidity Path / Exit Strategy\n* **Planned Public Listing**: Harbour has established a near-term pathway to liquidity via a planned **Reverse Takeover (RTO)** scheduled for **Q1 2024** [Page 3].\n",
"mime_type": "text/markdown",
"run_id": "27",
"sha256": "MTE1MjllNGYxZDkwMzhjNGY1YzNkNTg0NTQ2ZDIwYzBhY2E1MTVhNTc1NTZiMGM5ZTBmNGY5NDY4OWM3MWZlMQ==",
"state": "ACTIVE",
"store_name": "fileSearchStores/dealsworkflowproductionunkn-vknhwxca4dwr",
"system": "trigger",
"task_name": "pitch_deck_schema_strategy_and_portfolio",
"uri": "https://generativelanguage.googleapis.com/v1beta/files/z9b9k9ujhsqu"
},
{
"content": "{\n \"keyPrincipals\": [],\n \"firmLeadership\": [\n {\n \"firstName\": \"David\",\n \"lastName\": \"Craig\",\n \"title\": \"Chief Executive Officer\"\n },\n {\n \"firstName\": \"Alexander\",\n \"lastName\": \"Strezos\",\n \"title\": \"Chief Operating Officer\"\n },\n {\n \"firstName\": \"Setti\",\n \"lastName\": \"Coscarella\",\n \"title\": \"Vice President of Corporate Strategy\"\n },\n {\n \"firstName\": \"Alvaro\",\n \"lastName\": \"Concha\",\n \"title\": \"VP Corporate Development; Latin America\"\n }\n ],\n \"additionalTeamMembers\": [\n {\n \"firstName\": \"Harpreet\",\n \"lastName\": \"Hansra\",\n \"title\": \"Political Liaison, Canada\"\n }\n ],\n \"advisorsAndOperatingPartners\": [\n {\n \"firstName\": \"Gianpaolo\",\n \"lastName\": \"Caporiccio\",\n \"title\": \"Advisor\"\n },\n {\n \"firstName\": \"Peter E.\",\n \"lastName\": \"Simeon\",\n \"title\": \"Legal Advisor / Partner at Gowling WLG\"\n },\n {\n \"firstName\": \"John\",\n \"lastName\": \"Celenza\",\n \"title\": \"Advisor\"\n }\n ],\n \"performanceAsOfDate\": \"Not specified\",\n \"priorVehicles\": [],\n \"caseStudies\": [\n {\n \"companyName\": \"Stepan\"\n },\n {\n \"companyName\": \"Power Leaves Corp.\",\n \"currentOrExitValuation\": {\n \"source_number_text\": \"$100 million\",\n \"unit\": \"MONETARY\",\n \"currency\": \"USD\",\n \"exact_amount\": {\n \"amount\": 100,\n \"magnitude\": \"MILLIONS\"\n },\n \"normalized_exact_amount\": 100000000\n }\n }\n ]\n}",
"description": "Human-readable Markdown/RAG optimized response generated by the Pitch_deck_schema_team_and_track_record task.",
"developer_name": "unknown",
"display_name": "Pitch Deck Extractions - team_and_track_record Research Report",
"environment": "production",
"evaluation_metadata": {
"content_sha": "0359c0fa3e21524d9c849d8439d112d8e7d483fb766932d9468a921b464ea26b",
"data_type": "processed_output",
"deep_research_tool": "jina",
"document_group": "fund",
"entity_type": "fund",
"fund_id": "12",
"is_deep_research": true,
"is_research": true,
"origin": "deep_research_pipeline",
"run_id": "27",
"task_identifier": "pitch_deck_schema_team_and_track_record",
"task_name": "pitch_deck_schema_team_and_track_record",
"topic": "fund_harbour_ir_deck_nov2023_2__1_"
},
"expiration_time": "2026-07-24T18:29:07.713500628Z",
"file_extension": "md",
"file_size": 6409,
"gemini_create_time": "2026-07-22T18:29:07.879120Z",
"gemini_file_id": "files/i3wuwig70psa",
"gemini_update_time": "2026-07-22T18:29:07.879120Z",
"markdown_content": "# Pitch_deck_schema_team_and_track_record Response\n\n## Technical Context\n- **Task Name**: pitch_deck_schema_team_and_track_record\n- **Workflow Run ID**: 27\n- **Timestamp**: 2026-07-22T18:29:07.258Z\n\n## Grounded Intelligence Data\n# Team and Track Record\n\n### Leadership, Operational, and Advisory Team Members\n\nThe following individuals represent the leadership, operational, and advisory teams of Harbour Solutions Importation Inc. (the \"Company\" or \"Harbour\"):\n\n* **David Craig (CEO)**\n * **Role**: Chief Executive Officer [Page 15].\n * **Investment Team Classification (`isInvestmentTeam`)**: `false`. His primary role is executive leadership and operations rather than professional investing, underwriting, or fund-level deal sourcing.\n* **Alexander Strezos (COO)**\n * **Role**: Chief Operating Officer [Page 15].\n * **Investment Team Classification (`isInvestmentTeam`)**: `false`. His primary role is operational execution and management.\n* **Setti Coscarella (VP Corporate Strategy)**\n * **Role**: Vice President of Corporate Strategy [Page 15].\n * **Investment Team Classification (`isInvestmentTeam`)**: `false`. His primary role focuses on corporate strategy rather than active investment/underwriting.\n* **Gianpaolo Caporiccio (Advisor)**\n * **Role**: Advisor [Page 15].\n * **Investment Team Classification (`isInvestmentTeam`)**: `false`. Actively advises the leadership team but is not a professional investor or underwriter for a GP.\n* **Harpreet Hansra (Political Liaison, Canada)**\n * **Role**: Political Liaison, Canada [Page 15].\n * **Investment Team Classification (`isInvestmentTeam`)**: `false`. Role is specialized in political relations and regulatory liaison within Canada.\n* **Alvaro Concha (VP Corporate Development; Latin America)**\n * **Role**: VP Corporate Development; Latin America [Page 15].\n * **Key Background Details**: Former Colombia Trade Commissioner to Canada [Page 15].\n * **Investment Team Classification (`isInvestmentTeam`)**: `false`. Focused on corporate business development and regional expansion in Latin America.\n* **Peter E. Simeon (Partner at Gowling WLG; Legal Advisor)**\n * **Role**: Legal Advisor / Partner at Gowling WLG [Page 15].\n * **Investment Team Classification (`isInvestmentTeam`)**: `false`. Provides external legal counsel and compliance support.\n\n---\n\n### Corporate Capabilities, Track Record, and Achievements\n\nWhile Harbour is an operating company (rather than a traditional General Partner managing private equity or venture capital funds), the deck highlights the operational track record of its management, advisors, and corporate partnerships:\n\n* **Executive Track Record & Industry Experience**: \n * The team possesses over 50 years of collective experience across regulatory frameworks, consumer packaged goods (CPG), capital markets, and public market environments [Page 3].\n * C-level executives on the team have previously run corporations valued at more than $600 million [Page 3].\n * **John Celenza (Co-Founder of Bio Steel)** is highlighted as part of this seasoned advisory network, having built Bio Steel (a beverage brand) and successfully grown its revenues to over $140 million [Page 3].\n* **Regulatory & Operational Licensing Success**:\n * The operations team has a proven track record in securing cultivation and processing licenses from Health Canada within highly regulated substance markets, specifically cannabis [Page 15].\n * This pharmaceutical background in processing operations is utilized to enable safe, compliant, and high-margin conversion of raw materials into finished, decocainized products [Page 15].\n* **Key Corporate Milestones**:\n * **Historic Trade Agreement**: Secured and signed a long-term international supply agreement (5 years with auto-renewal) with Enaco, the Peruvian state-run coca leaf corporation, which was later ratified by the Peruvian Congress [Page 3, Page 12, Page 14]. This agreement supports over 35,000 registered local coca leaf farmers within Peru [Page 3, Page 14] and includes negotiated preferential pricing for all coca leaf and derivative products [Page 14].\n * **First-of-its-Kind Importation**: Successfully legally imported decocainized coca leaf extract into North America (specifically Canada) for commercialization for the first time [Page 3, Page 12].\n * **Municipal Support**: Obtained local municipal support (from Mayor Patrick Brown of Brampton, Ontario, via a Letter of Support dated April 19, 2023) to build a major processing facility and global corporate headquarters [Page 12, Page 22].\n * **Public Listing Path**: Harbour has planned a public listing via a Reverse Takeover (RTO) for Q1 2024 [Page 3].\n\n---\n\n### Comparables & Industry Case Studies\n\nThe pitch deck details two primary corporate comparables in the coca leaf processing and extraction space to illustrate the market opportunity, business model feasibility, and valuations:\n\n#### 1. Stepan\n* **Location / Ownership**: US-owned, based in New Jersey and New York [Page 10].\n* **Financial Metrics**: Generates $2.2 billion in annual revenue [Page 10].\n* **Operating Model & Thesis**: \n * Currently serves as the sole existing source of coca leaf extracts and active compound derivatives sold in Canada [Page 10].\n * Imports raw coca leaves directly from Peru [Page 10].\n * Acts as the primary supplier of flavor extracts (with active compounds/alkaloids removed) to Coca-Cola [Page 10].\n * Sells the isolated active compounds (alkaloids) to Mallinckrodt, a pharmaceutical firm that generated $3.2 billion in revenue in 2019, strictly for medicinal use [Page 10].\n* **Relevance to Harbour**: Toppling the monopoly held by Stepan is a core pillar of Harbour's strategy, which positions Harbour as the first Canadian-based source for these same materials [Page 11, Page 20].\n\n#### 2. Power Leaves Corp.\n* **Location / Ownership**: Based in Neiva, South Central Colombia [Page 10].\n* **Financial Metrics & Valuation**: Pre-revenue, with a current valuation of $100 million [Page 10].\n* **Operating Model & Thesis**:\n * Operates as a processor of Colombian coca leaves [Page 10].\n * Plans to supply international customers with food and beverage extracts that have had active compounds (alkaloids) removed [Page 10].\n",
"mime_type": "text/markdown",
"run_id": "27",
"sha256": "NDY2NTU3MTBkZTQ0MzVjNDgzOTU1M2NmMmJiNGEwN2I4Njc0N2RlMjdjNDZhNmIxYTg2MmUxYzU0YzA4MjdkMg==",
"state": "ACTIVE",
"store_name": "fileSearchStores/dealsworkflowproductionunkn-vknhwxca4dwr",
"system": "trigger",
"task_name": "pitch_deck_schema_team_and_track_record",
"uri": "https://generativelanguage.googleapis.com/v1beta/files/i3wuwig70psa"
},
{
"content": "{\n \"pipelineCompanies\": [\n {\n \"companyName\": \"Enaco\",\n \"sector\": \"Agriculture\",\n \"source\": \"Proprietary\",\n \"headquarters\": \"Peru\",\n \"description\": \"Empresa Nacional de la Coca, the Peruvian state-run coca leaf production company with an officially signed 5-year long-term international supply agreement with auto-renewal.\",\n \"status\": \"Closed\",\n \"coInvestors\": []\n }\n ]\n}",
"description": "Human-readable Markdown/RAG optimized response generated by the Pitch_deck_schema_warehoused_deals task.",
"developer_name": "unknown",
"display_name": "Pitch Deck Extractions - warehoused_deals Research Report",
"environment": "production",
"evaluation_metadata": {
"content_sha": "8258aa3d477a48dfc5807a0fc26e40946bb7b56fbf39a1923c60675e4db9dc04",
"data_type": "processed_output",
"deep_research_tool": "jina",
"document_group": "fund",
"entity_type": "fund",
"fund_id": "12",
"is_deep_research": true,
"is_research": true,
"origin": "deep_research_pipeline",
"run_id": "27",
"task_identifier": "pitch_deck_schema_warehoused_deals",
"task_name": "pitch_deck_schema_warehoused_deals",
"topic": "fund_harbour_ir_deck_nov2023_2__1_"
},
"expiration_time": "2026-07-24T18:29:17.820473537Z",
"file_extension": "md",
"file_size": 4958,
"gemini_create_time": "2026-07-22T18:29:18.025690Z",
"gemini_file_id": "files/wgsbnuzk47n1",
"gemini_update_time": "2026-07-22T18:29:18.025690Z",
"markdown_content": "# Pitch_deck_schema_warehoused_deals Response\n\n## Technical Context\n- **Task Name**: pitch_deck_schema_warehoused_deals\n- **Workflow Run ID**: 27\n- **Timestamp**: 2026-07-22T18:29:17.244Z\n\n## Grounded Intelligence Data\n# Warehoused Deals\n\nBased on the Harbour pitch deck, the company is presented as an operating entity seeking a public listing via Reverse Takeover (RTO) in Q1 2024 rather than a traditional multi-asset investment fund [Slide 3]. Consequently, traditional \"warehoused deals\" in the form of fund-seeded investment assets do not apply directly. However, the company has secured several foundational \"seed\" assets, exclusive supply agreements, proprietary product pipelines, and facility options that represent the core asset base being brought to public markets:\n\n### 1. Exclusive & Secured Raw Material Supply Agreements\n* **Historic Enaco Partnership:** Harbour has secured a historic partnership with Enaco (Empresa Nacional de la Coca), the Peruvian state-run coca leaf production company [Slide 3, Slide 13]. \n* **Long-Term Supply Certainty:** This consists of an officially signed, long-term international supply agreement with a 5-year duration featuring auto-renewal [Slide 14].\n* **Scale of Supply network:** The agreement legally supports and provides access to over 35,000 registered local coca leaf farmers in the Enaco network in Peru [Slide 3, Slide 14].\n* **Preferential Terms:** Harbour has negotiated preferential pricing for all coca leaf and coca leaf derivative products with Enaco [Slide 14]. This secures a consistent and expanding supply exported directly from Peru and imported into Canada [Slide 13].\n* **Proof-of-Concept Seed Importation:** Harbour has already successfully and legally imported decocainized coca leaf extract into Canada/North America for the first time, establishing the operational pathway [Slide 3, Slide 12].\n\n### 2. Proprietary In-House Brand & Product Pipeline (The Launch Portfolio)\nBefore transitioning to commercializing ingredients for external Consumer Packaged Goods (CPG) brands, Harbour is seeding its commercial operations with its own suite of proprietary brands [Slide 3]:\n* **Ratio (Brand):** A proprietary brand focused on performance and health, starting with \"Pure Plant Protein\" (a plant-based protein powder delivering 20g of protein and 100 calories per serving) [Slide 29, Slide 34].\n* **Constitution Nutraceuticals (Brand):** A proprietary brand launching \"Whole Body Vitality\" chewable tablets, which are plant-based dietary supplements utilizing coca leaf extract [Slide 30, Slide 34, Slide 35].\n* **Harbour Nootropic Beverages (Brand):** A proprietary brand of functional beverages [Slide 31]. The product line includes distinct SKUs such as:\n * \"ZZZZZ\" (coca leaf, damiana, and sarsaparilla active ingredients) [Slide 31, Slide 32, Slide 33]\n * \"Rough Night\" [Slide 32, Slide 33]\n * \"Hunker Down\" [Slide 32, Slide 33]\n * \"Mirror Mirror\" [Slide 32, Slide 33]\n * \"Super Excellent\" [Slide 32, Slide 33]\n * \"Get Some\" [Slide 32]\n * \"Warm Blanket\" [Slide 32]\n* **Launch Roadmap:** The initial launch portfolio consists of four primary internal products: an energy drink beverage, a lifestyle coca-infused water, a single-serve protein powder, and an energy shot [Slide 3].\n\n### 3. Pre-Identified Commercial & Distribution Pipeline\n* **CPG Brands Pipeline:** Harbour is in active, current discussions with several established CPG brands across North America to supply non-active coca leaf extracts [Slide 3].\n* **Distribution Contracts:** Distribution contracts for Harbour's in-house suite of brands (Ratio, Constitution, and Nootropic Beverages) are currently in the final stages of negotiation [Slide 3].\n* **Target Commercial Verticals:** The company has pre-identified and targeted key commercial customers across active pharmaceutical ingredients (APIs) and non-active extracts [Slide 23]:\n * **Active Compounds (Alkaloids):** Target pipeline pharmaceutical customers under independent Health Canada approved licenses include Sun Pharma, Apotex, GSK, and Taro [Slide 23].\n * **Non-Active Extracts:** Target pipeline commercial partners for flavor and consumer goods include Coca-Cola, Cott (for Walmart), Red Bull, Aesop, Tom Ford, and LUSH [Slide 23].\n\n### 4. Seeded Infrastructure & Real Estate Pipelines\n* **Brampton processing Facility Option:** Harbour has secured formal municipal support from Mayor Patrick Brown of Brampton, Ontario, to build its major processing facility and global corporate headquarters in the city of Brampton [Slide 22].\n* **Strategic Collocation:** The pre-identified facility location in Brampton is chosen for its proximity to key future stakeholders and logistics hubs, including Coca-Cola and Sun Pharmaceuticals [Slide 22].\n* **Academic/R&D Pipeline:** Harbour has developed plans to build a research arm to support co-op programs with Toronto Metropolitan University’s School of Medicine and Sheridan College [Slide 22].\n",
"mime_type": "text/markdown",
"run_id": "27",
"sha256": "ZGRkMTQyNjEwNmMzNjY5MGVhMzdiZWMwZDFlMjFjMTAxNmYwODViZjg3ZWUyZmY0ZGQ3ODRmZWI5YzM0YjE1ZA==",
"state": "ACTIVE",
"store_name": "fileSearchStores/dealsworkflowproductionunkn-vknhwxca4dwr",
"system": "trigger",
"task_name": "pitch_deck_schema_warehoused_deals",
"uri": "https://generativelanguage.googleapis.com/v1beta/files/wgsbnuzk47n1"
},
{
"content": "{\n \"corporate_names\": [\n {\n \"name\": \"Harbour Solutions Importation Inc.\",\n \"rationale\": \"Identified in the fund_overview_and_terms as both the fund name and the management company.\"\n },\n {\n \"name\": \"Gowling WLG\",\n \"rationale\": \"Identified as the legal partner firm providing advisory services to the company.\"\n },\n {\n \"name\": \"Stepan Company\",\n \"rationale\": \"Identified as the U.S.-based entity that currently holds a monopoly in the market, which the company is competing against.\"\n },\n {\n \"name\": \"Empresa Nacional de la Coca (ENACO)\",\n \"rationale\": \"Identified as the Peruvian state-run corporation and primary supply partner.\"\n }\n ],\n \"fund_names\": [\n {\n \"name\": \"Harbour Solutions Importation Inc. Fund Series I\",\n \"rationale\": \"Derived from the combination of the management company name and the specific fund series mentioned in the fund_overview_and_terms.\"\n }\n ],\n \"website\": \"null\",\n \"headquarters_city\": \"Brampton\",\n \"headquarters_state\": \"Ontario\",\n \"claimed_aum\": \"null\"\n}",
"description": "Human-readable Markdown/RAG optimized response generated for Harbour Solutions Importation Inc. by the Extracted_sec_entities task.",
"developer_name": "unknown",
"display_name": "Extracted SEC Entities Research Report",
"environment": "production",
"evaluation_metadata": {
"belongs_to": "Harbour Solutions Importation Inc.",
"content_sha": "f0142865d2993c7d58351e659c00f41514547c61036fbcd7de1f887a8369657d",
"data_type": "processed_output",
"deep_research_tool": "none",
"document_group": "fund",
"entity_type": "fund",
"fund_id": "12",
"is_deep_research": false,
"is_research": true,
"origin": "sec",
"run_id": "27",
"task_identifier": "extracted_sec_entities",
"task_name": "extracted_sec_entities",
"topic": "fund_harbour_ir_deck_nov2023_2__1_"
},
"expiration_time": "2026-07-24T18:29:32.679093992Z",
"file_extension": "md",
"file_size": 1181,
"gemini_create_time": "2026-07-22T18:29:32.862570Z",
"gemini_file_id": "files/wqyassdeaxar",
"gemini_update_time": "2026-07-22T18:29:32.862570Z",
"markdown_content": "# Extracted_sec_entities Response\n\n## Technical Context\n- **Task Name**: extracted_sec_entities\n- **Workflow Run ID**: 27\n- **Timestamp**: 2026-07-22T18:29:31.902Z\n\n## Grounded Intelligence Data\n## Corporate Names\n### Item #1\n**Name**: Harbour Solutions Importation Inc.\n\n**Rationale**: Identified in the fund_overview_and_terms as both the fund name and the management company.\n\n### Item #2\n**Name**: Gowling WLG\n\n**Rationale**: Identified as the legal partner firm providing advisory services to the company.\n\n### Item #3\n**Name**: Stepan Company\n\n**Rationale**: Identified as the U.S.-based entity that currently holds a monopoly in the market, which the company is competing against.\n\n### Item #4\n**Name**: Empresa Nacional de la Coca (ENACO)\n\n**Rationale**: Identified as the Peruvian state-run corporation and primary supply partner.\n\n## Fund Names\n### Item #1\n**Name**: Harbour Solutions Importation Inc. Fund Series I\n\n**Rationale**: Derived from the combination of the management company name and the specific fund series mentioned in the fund_overview_and_terms.\n\n**Website**: null\n\n**Headquarters City**: Brampton\n\n**Headquarters State**: Ontario\n\n**Claimed Aum**: null\n",
"mime_type": "text/markdown",
"run_id": "27",
"sha256": "N2JkZTY5NTkzMjdlYThjOTU0ZDY0ZWRjMWQ1ZWJiNmU0ZjdmYzY2OGYxNTA2ZGM5MzNmMDk1Njc0NTU5NGI0Yw==",
"state": "ACTIVE",
"store_name": "fileSearchStores/dealsworkflowproductionunkn-vknhwxca4dwr",
"system": "trigger",
"task_name": "extracted_sec_entities",
"uri": "https://generativelanguage.googleapis.com/v1beta/files/wqyassdeaxar"
}
],
"isEmerging": false,
"l1_analysis": null,
"managerClassification": "Established",
"manager_entity": {
"claimed_aum": "null",
"classification": "Established",
"has_custody": false,
"has_private_funds": false,
"has_regulatory_flags": false,
"headquarters_city": "Brampton",
"headquarters_state": "Ontario",
"is_emerging": false,
"is_sec_exempt": false,
"possible_corp_name": [
{
"name": "Harbour Solutions Importation Inc.",
"rationale": "Identified in the fund_overview_and_terms as both the fund name and the management company."
},
{
"name": "Gowling WLG",
"rationale": "Identified as the legal partner firm providing advisory services to the company."
},
{
"name": "Stepan Company",
"rationale": "Identified as the U.S.-based entity that currently holds a monopoly in the market, which the company is competing against."
},
{
"name": "Empresa Nacional de la Coca (ENACO)",
"rationale": "Identified as the Peruvian state-run corporation and primary supply partner."
}
],
"website": "null"
},
"processedPages": 0,
"runDirectory": "",
"saved_files": [
{
"bucket": "deals-analysis-staging",
"key": "all_files/9b8d5f1c13dd49e1efc0cf75f8593027bfc21ffdecd1f5ea546dd9a80a07d19d"
},
{
"bucket": "deals-analysis-staging",
"key": "all_files/9b8d5f1c13dd49e1efc0cf75f8593027bfc21ffdecd1f5ea546dd9a80a07d19d"
},
{
"bucket": "deals-analysis-staging",
"key": "all_files/c357e5e6901734ff17f1c97c543de108de67497cfba463b5f1ddfd602b31d47a"
},
{
"bucket": "deals-analysis-staging",
"key": "all_files/44136fa355b3678a1146ad16f7e8649e94fb4fc21fe77e8310c060f61caaff8a"
},
{
"bucket": "deals-analysis-staging",
"key": "all_files/44136fa355b3678a1146ad16f7e8649e94fb4fc21fe77e8310c060f61caaff8a"
},
{
"bucket": "deals-analysis-staging",
"key": "all_files/d4f34013234bc1164029aa66fdc072a06aa48375f9d82bcd5a8464dd45d5366c"
},
{
"bucket": "deals-analysis-staging",
"key": "all_files/e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855"
},
{
"bucket": "deals-analysis-staging",
"key": "all_files/f78c92be224625e5a8791e9e7a0d6c5e492512ee1af164da14df2d76f55cbd6e"
}
],
"sec_diligence": {
"discoveredEntities": {},
"fundName": "Harbour IR Deck Nov2023 2 (1)",
"metrics": {
"successfulExtractions": 0,
"totalCostFormatted": "$0.000206",
"totalCostUsd": 2.055e-4,
"totalDurationMs": 0
},
"primaryDocs": [],
"savedFiles": [],
"secExecutives": [],
"secWebsiteUrls": []
},
"sha256": "2a09b8bbbbedd6c5339ae9619ec9ac9704f1ab7f6e2a840357a88b1146389363",
"slides": [],
"source_material": {
"extracted_pages": {
"agent_pass": [
{
"data": {
"agent_markdown_context": "# fund_overview_and_terms\n\n### Executive Summary & Note on Entity Structure\nThe provided presentation represents a corporate investment opportunity in an operating company rather than a traditional private equity, venture capital, or real estate fund. Consequently, the terms, structure, and risk management criteria below reflect the corporate organization, regulatory classification, and pathway to liquidity for **Harbour Solutions Importation Inc.**, serving as the functional equivalent of a fund's structural terms [Page 2].\n\n---\n\n### Corporate Identity & Management Company\n* **Formal Entity Name:** Harbour Solutions Importation Inc. (referred to as \"the Company\" or \"Harbour\") [Page 2].\n* **Headquarters & Domicile:** Headquartered and domiciled in Canada [Page 3, Page 12].\n* **Management Maturity & Experience:** \n * Described as \"Seasoned executive management and advisory\" with over 50 years of cumulative regulatory, CPG, capital, and public market experience [Page 3].\n * Key executives have experience running corporations valued at $600 million+ [Page 3]. \n * Notable leadership includes John Celenza, Co-Founder of Bio Steel, who previously scaled that brand to over $140 million in revenue [Page 3].\n * The operations team has a track record of successfully securing cultivation and processing licenses from Health Canada in regulated substance markets (specifically Cannabis) [Page 15].\n\n---\n\n### Investment Strategy & Offering Terms\n* **Asset Class / Industry Focus:** Agriculture, Biotechnology, Pharmaceuticals, and Consumer Packaged Goods (CPG) focused on the legal importation, processing, and distribution of the *Erythroxylum coca* (coca plant) and its active/non-active derivatives [Page 1, Page 5].\n* **Business & Capital Deployment Model:** \n * \"Capital light business model\" wherein Harbour deploys capital to build revenue through strategic partnerships rather than committing to major capital expenditures [Page 12].\n * The supplier serves as a manufacturer, providing a short path to commercialization via immediate co-packing options [Page 3].\n* **Target Verticals & Market Size:**\n * **Active Pharmaceutical Ingredients (APIs):** Target addressable pharmaceutical market size of $344 billion (including Diet & Weight Loss at $175.2B, ADHD Medication at $32.24B, Local Anesthetics at $2.6B, Anti-Inflammatory Medications at $111.42B, and Vasoconstriction in Capillaries at $6B) [Page 3, Page 5].\n * **Consumer Goods (Non-Active Compounds):** Target addressable market of $1 Trillion+ (including Energy Drinks at $53.1B, Global Functional Foods at $305.4B, Nutraceuticals at $423B, and Beauty & Personal Care at $579B) [Page 3, Page 5].\n * **Commercial Fertilizer:** Target addressable market of $268 billion [Page 5] (elsewhere referenced as a $200 billion market [Page 3, Page 18]).\n* **Pathway to Liquidity (Fund Life / Horizon Equivalent):** \n * The Company has a public listing planned via a Reverse Takeover (RTO) scheduled for Q1 2024 [Page 3].\n\n---\n\n### Key Legal, Regulatory, and Government Entities\n* **Legal Advisor:** Gowling WLG, which provides legal representation, assists in navigating compliance requirements, and facilitates strategic value chain partnerships [Page 15, Page 21]. Peter E. Simeon is named as Partner at Gowling WLG and Legal Advisor to Harbour [Page 15].\n* **Regulatory Oversight Bodies:** Harbour collaborates and maintains ongoing regulatory discussions with:\n * Health Canada [Page 12, Page 15, Page 23]\n * Canadian Food Inspection Agency (CFIA) [Page 12]\n * Royal Canadian Mounted Police (RCMP-GRC) [Page 12]\n * Canada Border Services Agency (CBSA) [Page 12]\n* **Strategic Supply Partner:** ENACO (*Empresa Nacional de la Coca*), the Peruvian state-run coca leaf corporation [Page 13, Page 14]. \n * Harbour has officially signed a 5-year international supply agreement with ENACO featuring an automatic renewal clause [Page 14].\n * The agreement includes negotiated \"preferential pricing\" for all coca leaves and coca leaf derivative products [Page 14].\n * ENACO represents a network of over 35,000 registered local coca leaf farmers in Peru [Page 3, Page 14].\n* **Municipal Government Partner:** City of Brampton, Ontario, Canada [Page 22].\n * Brampton Mayor Patrick Brown issued a formal Letter of Support dated April 19, 2023, endorsing Harbour's intention to establish its major processing facility and global corporate headquarters in the municipality [Page 22].\n\n---\n\n### Regulatory Exemptions & Operational Status\n* **Exemptions & First-Mover Status:** \n * Successfully legally imported decocainized coca leaf extract into Canada/North America for commercialization [Page 3, Page 12].\n * Positioned as the first Canadian source of coca leaves and their derivative products, challenging the existing US monopoly held by Stepan [Page 10, Page 11, Page 20].\n * Operational framework is aligned with the Canadian government's ongoing investigation into alternative frameworks to prevent harm caused by opioids (\"Safe Supply\" initiatives) [Page 3, Page 24].\n\n---\n\n### Explicit Risk Disclosures for Investors\nAccording to the formal Legal Disclaimer, potential investors are subject to the following key risks [Page 2]:\n* **Speculative Nature:** Investments in the Company are speculative and carry no guarantee of performance or returns [Page 2].\n* **Lack of Liquidity:** There is currently no liquid market for the Company's securities [Page 2].\n* **Capital Requirements:** The Company requires additional funding to execute its business strategies [Page 2].\n* **Regulatory and Licensing Risks:** The business is highly dependent on securing, maintaining, and complying with required licenses, permits, and authorizations from various levels of government [Page 2].\n* **Legal Uncertainty:** Risks associated with changes in local or international laws, or the non-occurrence of anticipated legal/policy changes [Page 2].\n* **Banking and Financial Services Access:** Risks of potential denial of banking services due to the specific regulatory nature of the industry in which the Company operates [Page 2].\n* **Insurance Risks:** Risks related to the denial of insurance coverage or the inability to obtain insurance coverage at reasonable rates [Page 2].\n* **Third-Party Reliance:** Heavy operational reliance on third-party suppliers and partners (such as ENACO) [Page 2, Page 13].\n* **Public and Legislative Acceptance:** Operational success is subject to acceptance by the general public and legislators [Page 2].",
"citations": [],
"payload": {
"fund_overview_and_terms": {
"attributedTrackRecord": "John Celenza scaled Bio Steel to over $140 million in revenue, and key executives have run corporations valued at $600 million+.",
"classificationReasoning": "The provided presentation represents a corporate investment opportunity in an operating company rather than a traditional private equity, venture capital, or real estate fund.",
"diversityClaims": [],
"domicile": "Canada",
"fundName": "Harbour Solutions Importation Inc.",
"fundSeries": "I",
"isFirstTimeFund": true,
"isOpenEnded": false,
"keyRiskDisclosures": [
"Speculative Nature",
"Lack of Liquidity",
"Capital Requirements",
"Regulatory and Licensing Risks",
"Legal Uncertainty",
"Banking and Financial Services Access",
"Insurance Risks",
"Third-Party Reliance",
"Public and Legislative Acceptance"
],
"managementCompany": "Harbour Solutions Importation Inc.",
"managerClassification": "Established",
"maturityClassificationReasoning": "The management team has over 50 years of cumulative experience, with key executives having experience running corporations valued at $600 million+.",
"primaryAssetClass": "Unknown",
"regulatoryExemptions": [],
"vintageYear": "2024"
}
}
},
"schemaKey": "fund_overview_and_terms"
},
{
"data": {
"agent_markdown_context": "# Strategy and Portfolio\n\n### Executive Analyst Summary\nHarbour Solutions Importation Inc. positioning as the first authorized Canadian importer and processor of legal Peruvian coca leaves presents a highly lucrative, first-mover opportunity to dismantle a long-standing U.S. monopoly in the multi-billion dollar active and non-active compound markets. By securing a historic, exclusive five-year state-sanctioned supply agreement with Peru's ENACO, Harbour mitigates critical regulatory barriers and establishes a capital-light, high-margin business model designed to supply both the $344 billion pharmaceutical API sector and the $1 trillion+ consumer packaged goods market. Backed by experienced municipal, political, and regulatory leaders, the company is poised to capture significant market share across multiple verticals, including functional beverages, cosmetics, nutraceuticals, and organic fertilizers, ahead of a planned public listing. [Page 1, Page 2, Page 3, Page 10, Page 11, Page 12]\n\n---\n\n### Core Qualitative Narrative and Investment Thesis\n\n#### Primary Investment Objective & Thesis\n* **Disrupting Monopolistic Multi-Billion Dollar Markets**: Harbour aims to capitalize on a \"once-in-a-generation\" market opportunity by introducing competition to a space previously monopolized by a single U.S.-based entity, Stepan Company [Page 3, Page 10]. \n* **The \"First-Mover\" Advantage in Canada**: Harbour is positioned as the first Canadian source of coca leaves and their derivative products [Page 11]. This enables Canadian and international brands to tap into the therapeutic and flavor profiles of the coca plant legally in North America [Page 8, Page 11].\n* **Active vs. Non-Active Compound Bifurcation**: The core investment thesis relies on extracting and separating the coca leaf's compounds into two highly valuable revenue streams:\n * *Active Compounds (Alkaloids)*: Sold directly to authorized pharmaceutical companies for medicinal applications [Page 5, Page 19, Page 23].\n * *Non-Active Compounds (Decocainized Extracts)*: Used as flavorings and bio-functional ingredients in global consumer packaged goods (CPG) with zero psychoactive effects [Page 5, Page 19, Page 23].\n\n#### Market Opportunities & Addressable Markets\n* **Total Addressable Pharmaceutical Market**: Valued at **$344 billion** globally (as of 2022) [Page 3, Page 5]. Specific addressable medical applications include:\n * Diet & Weight Loss: **$175.2 billion** [Page 5]\n * ADHD Medication: **$32.24 billion** [Page 5]\n * Anti-Inflammatory Medications: **$111.42 billion** [Page 5]\n * Vasoconstriction in Capillaries: **$6.0 billion** [Page 5]\n * Local Anesthetics: **$2.6 billion** [Page 5]\n* **Total Addressable Consumer Goods Market**: Valued at **$1.0 trillion+** globally (as of 2022) [Page 3, Page 5]. Specific addressable categories include:\n * Beauty & Personal Care: **$579.0 billion** [Page 5]\n * Nutraceuticals: **$382.0 billion** to **$423.0 billion** [Page 4, Page 5]\n * Global Functional Foods: **$275.0 billion** to **$305.4 billion** [Page 4, Page 5]\n * Fertilizers for Commercial Agriculture: **$200.0 billion** to **$268.0 billion** [Page 3, Page 5, Page 18]\n * Energy Drinks: **$50.0 billion** to **$53.1 billion** [Page 4, Page 5]\n\n#### Sourcing Strategies & Global Partnerships\n* **State-Sanctioned Monopolistic Partnership**: Harbour has secured a historic, legally binding trade agreement with **ENACO** (Empresa Nacional de la Coca), the Peruvian state-run corporation which controls the oldest and largest legal source of coca leaves globally [Page 3, Page 13, Page 14].\n* **Agreement Scope and Farmers Network**: The international supply agreement is a **5-year contract with automatic renewal** [Page 14]. This contract directly supports and sources from a network of over **35,000 registered local Peruvian coca leaf farmers** [Page 3, Page 14].\n* **Preferential Pricing**: Harbour has negotiated preferential, exclusive pricing structures with ENACO for all raw coca leaves and derivative products [Page 14].\n* **Ratification and Legality**: The trade agreement was fully ratified by the Peruvian Congress, assuring sovereign-level legal protection and compliance [Page 12].\n\n#### Value Creation Playbook & Operating Model\n* **The Decocainization & Extraction Loop**: The proprietary extraction process consists of importing raw leaves from ENACO under strict government regulations, executing secure transit, and processing them in a certified Canadian facility [Page 23].\n * *Step 1*: Raw leaves go into the Coca Extractor [Page 19].\n * *Step 2*: Separation into an Alkaloid Rich Extract and an Alkaloid Free Extract [Page 19].\n * *Step 3*: The Alkaloid Rich Extract yields active pharmaceutical compounds [Page 19, Page 23].\n * *Step 4*: The Alkaloid Free Extract is processed into high-margin liquid or powder extracts for commercial CPG applications [Page 19, Page 23].\n* **Capital-Light Business Model**: Instead of executing major capital expenditures, Harbour deploys its capital to generate revenue through strategic manufacturing and co-packing partnerships [Page 12].\n* **Turnkey Co-Packing Capabilities**: The Peruvian supplier also acts as a manufacturer, offering immediate co-packing opportunities that drastically shorten the traditional path to commercialization [Page 3].\n\n#### GP Competitive Edge & Barriers to Entry\n* **Regulatory Exclusivity & Compliance**: Harbour operates with full compliance under municipal, provincial, and federal regulations [Page 13]. The operations team possesses a proven track record of securing cultivation and processing licenses from **Health Canada** in complex regulated substance markets (e.g., Cannabis) [Page 15].\n* **Strong Political Currency**: Harbour has obtained significant political and law enforcement support in Canada [Page 20]. The company is actively collaborating with regulatory bodies, including Health Canada, the Canadian Food Inspection Agency (CFIA), the Royal Canadian Mounted Police (RCMP), and the Canada Border Services Agency (CBSA) [Page 12].\n* **Sovereign Legal Advisory**: Legal representation and compliance navigation are led by **Gowling WLG**, a top-tier legal team specializing in pharma, biotech, and complex mergers & acquisitions [Page 21].\n* **Municipal Infrastructure Support**: Harbour has received formal support from the municipal government of Brampton, Ontario [Page 12, Page 22]. In a Letter of Support dated April 19, 2023, Mayor Patrick Brown endorsed Harbour's plans to build a processing facility and establish its global corporate headquarters in Brampton, highlighting its role as a key logistics hub near stakeholders like Coca-Cola and Sun Pharmaceuticals [Page 22].\n\n---\n\n### Portfolio Construction Parameters & Business Model\n\n#### Three Main Verticals & Product Offerings\nHarbour builds its portfolio around three core operational verticals [Page 3]:\n\n| Vertical | Market Size | Portfolio Parameters & Core Offerings |\n| :--- | :--- | :--- |\n| **Active Pharmaceutical Ingredients (APIs)** | $344 Billion [Page 3] | • Alkaloids sold to pharmaceutical firms for prescription therapeutics.<br>• Target uses: Diet/weight loss, ADHD meds, local anesthetics, anti-inflammatories [Page 5]. |\n| **CPG Brand Ingredients & Direct Brands** | $1 Trillion+ [Page 3] | • Supplying decocainized flavorings to blue-chip global brands [Page 12, Page 16].<br>• Launching proprietary in-house brands: \"Ratio\" (Pure Plant Protein) and \"Constitution Nutraceuticals\" (Whole Body Vitality) [Page 29, Page 30, Page 34].<br>• Launching a portfolio of nootropic lifestyle beverages [Page 3, Page 31, Page 32, Page 33]. |\n| **Fertilizer Ingredients** | $200 Billion [Page 3] | • Commercial-grade organic liquid fertilizers produced locally in Canada [Page 18].<br>• Promotes higher crop yields relative to traditional nitrogen fertilizers [Page 18]. |\n\n#### Target Geographies and Regulatory Frameworks\n* **Canada as a Launchpad**: Harbour is headquartered in Canada, leveraging the country's position as one of the first G7 nations to actively explore the descheduling of controlled substances [Page 3]. \n* **Safe Supply Movement Exemption**: The city of Vancouver has already received exemptions to deschedule drugs, with proposals under consideration to expand this framework nationwide [Page 3]. Harbour is positioned to satisfy the government's need for a safe, non-organized-crime-affiliated supply chain of raw materials [Page 3].\n* **Federal Framework Alignment**: Harbour is structuring its operations to align with the Canadian government's ongoing investigation into safe frameworks to prevent harm caused by synthetic opioids [Page 24].\n\n#### Partnerships and Customer Target Architecture\nHarbour has structured its business model to target two clear segments of enterprise customers [Page 23]:\n\n```\n [Raw Coca Leaf Importation (ENACO)]\n │\n [Secure Transport Link]\n │\n [Canadian Processing Hub]\n ┌┴┐\n ┌───────────────────────────┘ └────────────────────────────┐\n ▼ ▼\n [Active Compounds (Alkaloids)] [Non-Active Extracts]\n │ │\n ┌────────┴────────┬────────┐ ┌────────┬───────┼────────┬───────┐\n ▼ ▼ ▼ ▼ ▼ ▼ ▼ ▼\n[Sun Pharma] [Apotex] [GSK] [Coca-Cola] [Cott] [Redbull] [Aesop] [Lush]\n```\n\n* **Target Pharma API Clients**: Includes Johnson & Johnson ($96.26B revenue), Bayer ($47.5B revenue), AstraZeneca ($44.35B revenue), Merck ($42.84B revenue), Pfizer ($18.28B revenue), Sun Pharma ($5.1B revenue), Apotex ($1.2B revenue), and GSK ($1.07B revenue) [Page 9, Page 23].\n* **Target Non-Active Extract Clients**: Includes Coca-Cola ($43B revenue), Redbull ($10.2B revenue), Cott Beverage/Walmart ($2B revenue), LUSH ($1.06B revenue), Tom Ford ($654M revenue), and Aesop ($537M revenue) [Page 8, Page 23].\n\n---\n\n### Financial Models & Projected Returns\n\n#### Modeled Margins and Projected Returns\nThe company's commercialized offerings are characterized by exceptionally high return-on-investment (ROI) structures and gross margin profiles at scale [Page 3]:\n* **Active Pharmaceutical Ingredients (APIs)**: Projected to deliver a **20x ROI** [Page 3].\n* **Decocainized Extracts**: Projected to operate at a **~80% gross margin** [Page 3].\n* **Organic Fertilizers**: Projected to operate at a **~50% to 60% gross margin** [Page 3].\n\n#### Key Comparables and Competitive Valuation\nHarbour's competitive analysis features two primary comparables to highlight its valuation and market potential [Page 10]:\n* **Stepan Company (US)**:\n * *Revenue & Status*: A US-owned, publicly traded company (based in New Jersey/New York) generating **$2.2 billion in annual revenue** [Page 10].\n * *Role*: Historically, the *only* legal importer of coca leaves from Peru to North America. Stepan processes the leaves, sells the flavor extracts to Coca-Cola, and sells the extracted active alkaloid compounds to Mallinckrodt (a pharmaceutical firm with $3.2 billion in 2019 revenue) for medicinal use [Page 10].\n * *Implication*: Stepan represents a direct model of Harbour's operational strategy, confirming the viability of a dual-revenue extraction business [Page 10, Page 23].\n* **Power Leaves Corp. (Colombia)**:\n * *Valuation & Status*: A Colombia-based, pre-revenue start-up valued at **$100 million** [Page 10].\n * *Role*: Processors of Colombian coca leaves with plans to export decocainized extracts internationally [Page 10].\n * *Implication*: Demonstrates that even at pre-revenue stages, legal coca processing businesses command premium venture-scale valuations [Page 10].\n\n#### Liquidity Path / Exit Strategy\n* **Planned Public Listing**: Harbour has established a near-term pathway to liquidity via a planned **Reverse Takeover (RTO)** scheduled for **Q1 2024** [Page 3].",
"citations": [],
"payload": {
"strategy_and_portfolio": {
"analystSummary": "Harbour Solutions Importation Inc. positions itself as a first-mover by establishing the first authorized Canadian channel to import and process legal Peruvian coca leaves, effectively breaking a long-standing U.S. monopoly. Leveraging an exclusive, state-sanctioned five-year supply agreement with Peru's ENACO, the company separates raw leaves into high-margin pharmaceutical alkaloids and decocainized flavoring extracts for global consumer brands. Backed by key Canadian regulatory relationships and municipal support, the company operates a capital-light, partner-driven model designed to capture substantial share across multi-billion dollar verticals ahead of its planned Q1 2024 public listing.",
"assetClass": "Private Equity",
"capitalRecycling": "Not specified",
"coInvestmentRights": "Not specified",
"concentrationLimits": "Not specified",
"dealSourcingStrategy": "Securing a historic, legally binding, exclusive 5-year trade agreement with ENACO (Empresa Nacional de la Coca), the Peruvian state-run corporation which controls the oldest and largest legal source of coca leaves globally [Page 3, Page 13, Page 14].",
"illustrativeScenarios": [],
"investmentThesis": "The core investment thesis relies on extracting and separating the coca leaf's compounds into two highly valuable revenue streams: Active Compounds (Alkaloids) sold directly to authorized pharmaceutical companies for medicinal applications, and Non-Active Compounds (Decocainized Extracts) used as flavorings and bio-functional ingredients in global consumer packaged goods (CPG) with zero psychoactive effects [Page 5, Page 19, Page 23].",
"keyClaims": [
"Secured a historic, legally binding 5-year exclusive trade agreement with Peru's ENACO, backed by over 35,000 registered local coca leaf farmers [Page 3, Page 14].",
"Positioned as the first Canadian source of legal coca leaves and derivative products, dismantling a long-standing U.S. monopoly held by Stepan Company [Page 3, Page 10, Page 11].",
"Targets a $344 billion global pharmaceutical market and a $1.0 trillion+ global consumer goods market [Page 3, Page 5].",
"Active Pharmaceutical Ingredients (APIs) are projected to deliver a 20x ROI, while Decocainized Extracts operate at a ~80% gross margin [Page 3].",
"Formally supported by the municipal government of Brampton, Ontario, providing an endorsement to build a processing facility and global headquarters in a key logistics hub [Page 12, Page 22].",
"Partnered with top-tier legal team Gowling WLG to navigate complex sovereign-level compliance, pharma, biotech, and mergers & acquisitions [Page 21]."
],
"leadInvestorStatus": "Other",
"leverageLimits": "Not specified",
"modelAssumptions": [
"Active Pharmaceutical Ingredients (APIs) deliver a 20x ROI [Page 3]",
"Decocainized Extracts operate at a ~80% gross margin [Page 3]",
"Organic Fertilizers operate at a ~50% to 60% gross margin [Page 3]"
],
"primaryObjective": "Disrupting monopolistic multi-billion dollar markets by introducing competition to a space previously monopolized by a single U.S.-based entity, Stepan Company [Page 3, Page 10].",
"qualitativeThemes": [
"Market Disruption",
"Regulatory Exclusivity & Compliance",
"Capital-Light Scale",
"Sovereign Strategic Partnerships"
],
"targetGeographies": [
"Canada",
"Peru"
],
"targetReturns": {
"cashYield": {
"is_applicable": false,
"not_applicable_reason": "Not specified for this corporate equity investment opportunity"
},
"grossIrr": {
"is_applicable": false,
"not_applicable_reason": "Not specified for this corporate equity investment opportunity"
},
"grossMoic": {
"is_applicable": true,
"not_applicable_reason": "Not specified for this corporate equity investment opportunity in aggregate, though specific segment ROI is modeled [Page 3]. Only individual product ROI is provided, not fund-level MOIC."
},
"netIrr": {
"is_applicable": false,
"not_applicable_reason": "Not specified for this corporate equity investment opportunity"
},
"netMoic": {
"is_applicable": false,
"not_applicable_reason": "Not specified for this corporate equity investment opportunity"
}
},
"targetSectors": [
"Pharmaceuticals",
"Consumer Packaged Goods (CPG)",
"Nutraceuticals",
"Functional Beverages",
"Cosmetics",
"Organic Fertilizers"
],
"targetStages": [
"Growth Equity",
"Pre-IPO"
],
"valueCreationPlaybook": [
"Importing raw leaves from ENACO under strict government regulations, executing secure transit, and processing them in a certified Canadian facility [Page 23].",
"Separating raw leaves into an Alkaloid Rich Extract (for pharmaceuticals) and an Alkaloid Free Extract (for commercial CPG applications) [Page 19, Page 23].",
"Deploying a capital-light business model through strategic manufacturing and co-packing partnerships instead of heavy capital expenditures [Page 12].",
"Leveraging formal support from the municipal government of Brampton, Ontario to build a processing facility and establish its global corporate headquarters near key logistical stakeholders [Page 12, Page 22]."
]
}
}
},
"schemaKey": "strategy_and_portfolio"
},
{
"data": {
"agent_markdown_context": "# Team and Track Record\n\n### Leadership, Operational, and Advisory Team Members\n\nThe following individuals represent the leadership, operational, and advisory teams of Harbour Solutions Importation Inc. (the \"Company\" or \"Harbour\"):\n\n* **David Craig (CEO)**\n * **Role**: Chief Executive Officer [Page 15].\n * **Investment Team Classification (`isInvestmentTeam`)**: `false`. His primary role is executive leadership and operations rather than professional investing, underwriting, or fund-level deal sourcing.\n* **Alexander Strezos (COO)**\n * **Role**: Chief Operating Officer [Page 15].\n * **Investment Team Classification (`isInvestmentTeam`)**: `false`. His primary role is operational execution and management.\n* **Setti Coscarella (VP Corporate Strategy)**\n * **Role**: Vice President of Corporate Strategy [Page 15].\n * **Investment Team Classification (`isInvestmentTeam`)**: `false`. His primary role focuses on corporate strategy rather than active investment/underwriting.\n* **Gianpaolo Caporiccio (Advisor)**\n * **Role**: Advisor [Page 15].\n * **Investment Team Classification (`isInvestmentTeam`)**: `false`. Actively advises the leadership team but is not a professional investor or underwriter for a GP.\n* **Harpreet Hansra (Political Liaison, Canada)**\n * **Role**: Political Liaison, Canada [Page 15].\n * **Investment Team Classification (`isInvestmentTeam`)**: `false`. Role is specialized in political relations and regulatory liaison within Canada.\n* **Alvaro Concha (VP Corporate Development; Latin America)**\n * **Role**: VP Corporate Development; Latin America [Page 15].\n * **Key Background Details**: Former Colombia Trade Commissioner to Canada [Page 15].\n * **Investment Team Classification (`isInvestmentTeam`)**: `false`. Focused on corporate business development and regional expansion in Latin America.\n* **Peter E. Simeon (Partner at Gowling WLG; Legal Advisor)**\n * **Role**: Legal Advisor / Partner at Gowling WLG [Page 15].\n * **Investment Team Classification (`isInvestmentTeam`)**: `false`. Provides external legal counsel and compliance support.\n\n---\n\n### Corporate Capabilities, Track Record, and Achievements\n\nWhile Harbour is an operating company (rather than a traditional General Partner managing private equity or venture capital funds), the deck highlights the operational track record of its management, advisors, and corporate partnerships:\n\n* **Executive Track Record & Industry Experience**: \n * The team possesses over 50 years of collective experience across regulatory frameworks, consumer packaged goods (CPG), capital markets, and public market environments [Page 3].\n * C-level executives on the team have previously run corporations valued at more than $600 million [Page 3].\n * **John Celenza (Co-Founder of Bio Steel)** is highlighted as part of this seasoned advisory network, having built Bio Steel (a beverage brand) and successfully grown its revenues to over $140 million [Page 3].\n* **Regulatory & Operational Licensing Success**:\n * The operations team has a proven track record in securing cultivation and processing licenses from Health Canada within highly regulated substance markets, specifically cannabis [Page 15].\n * This pharmaceutical background in processing operations is utilized to enable safe, compliant, and high-margin conversion of raw materials into finished, decocainized products [Page 15].\n* **Key Corporate Milestones**:\n * **Historic Trade Agreement**: Secured and signed a long-term international supply agreement (5 years with auto-renewal) with Enaco, the Peruvian state-run coca leaf corporation, which was later ratified by the Peruvian Congress [Page 3, Page 12, Page 14]. This agreement supports over 35,000 registered local coca leaf farmers within Peru [Page 3, Page 14] and includes negotiated preferential pricing for all coca leaf and derivative products [Page 14].\n * **First-of-its-Kind Importation**: Successfully legally imported decocainized coca leaf extract into North America (specifically Canada) for commercialization for the first time [Page 3, Page 12].\n * **Municipal Support**: Obtained local municipal support (from Mayor Patrick Brown of Brampton, Ontario, via a Letter of Support dated April 19, 2023) to build a major processing facility and global corporate headquarters [Page 12, Page 22].\n * **Public Listing Path**: Harbour has planned a public listing via a Reverse Takeover (RTO) for Q1 2024 [Page 3].\n\n---\n\n### Comparables & Industry Case Studies\n\nThe pitch deck details two primary corporate comparables in the coca leaf processing and extraction space to illustrate the market opportunity, business model feasibility, and valuations:\n\n#### 1. Stepan\n* **Location / Ownership**: US-owned, based in New Jersey and New York [Page 10].\n* **Financial Metrics**: Generates $2.2 billion in annual revenue [Page 10].\n* **Operating Model & Thesis**: \n * Currently serves as the sole existing source of coca leaf extracts and active compound derivatives sold in Canada [Page 10].\n * Imports raw coca leaves directly from Peru [Page 10].\n * Acts as the primary supplier of flavor extracts (with active compounds/alkaloids removed) to Coca-Cola [Page 10].\n * Sells the isolated active compounds (alkaloids) to Mallinckrodt, a pharmaceutical firm that generated $3.2 billion in revenue in 2019, strictly for medicinal use [Page 10].\n* **Relevance to Harbour**: Toppling the monopoly held by Stepan is a core pillar of Harbour's strategy, which positions Harbour as the first Canadian-based source for these same materials [Page 11, Page 20].\n\n#### 2. Power Leaves Corp.\n* **Location / Ownership**: Based in Neiva, South Central Colombia [Page 10].\n* **Financial Metrics & Valuation**: Pre-revenue, with a current valuation of $100 million [Page 10].\n* **Operating Model & Thesis**:\n * Operates as a processor of Colombian coca leaves [Page 10].\n * Plans to supply international customers with food and beverage extracts that have had active compounds (alkaloids) removed [Page 10].",
"citations": [],
"payload": {
"team_and_track_record": {
"additionalTeamMembers": [
{
"firstName": "Harpreet",
"lastName": "Hansra",
"title": "Political Liaison, Canada"
}
],
"advisorsAndOperatingPartners": [
{
"firstName": "Gianpaolo",
"lastName": "Caporiccio",
"title": "Advisor"
},
{
"firstName": "Peter E.",
"lastName": "Simeon",
"title": "Legal Advisor / Partner at Gowling WLG"
},
{
"firstName": "John",
"lastName": "Celenza",
"title": "Advisor"
}
],
"caseStudies": [
{
"companyName": "Stepan"
},
{
"companyName": "Power Leaves Corp.",
"currentOrExitValuation": {
"currency": "USD",
"exact_amount": {
"amount": 100,
"magnitude": "MILLIONS"
},
"normalized_exact_amount": 100000000,
"source_number_text": "$100 million",
"unit": "MONETARY"
}
}
],
"firmLeadership": [
{
"firstName": "David",
"lastName": "Craig",
"title": "Chief Executive Officer"
},
{
"firstName": "Alexander",
"lastName": "Strezos",
"title": "Chief Operating Officer"
},
{
"firstName": "Setti",
"lastName": "Coscarella",
"title": "Vice President of Corporate Strategy"
},
{
"firstName": "Alvaro",
"lastName": "Concha",
"title": "VP Corporate Development; Latin America"
}
],
"keyPrincipals": [],
"performanceAsOfDate": "Not specified",
"priorVehicles": []
}
}
},
"schemaKey": "team_and_track_record"
},
{
"data": {
"agent_markdown_context": "# Warehoused Deals\n\nBased on the Harbour pitch deck, the company is presented as an operating entity seeking a public listing via Reverse Takeover (RTO) in Q1 2024 rather than a traditional multi-asset investment fund [Slide 3]. Consequently, traditional \"warehoused deals\" in the form of fund-seeded investment assets do not apply directly. However, the company has secured several foundational \"seed\" assets, exclusive supply agreements, proprietary product pipelines, and facility options that represent the core asset base being brought to public markets:\n\n### 1. Exclusive & Secured Raw Material Supply Agreements\n* **Historic Enaco Partnership:** Harbour has secured a historic partnership with Enaco (Empresa Nacional de la Coca), the Peruvian state-run coca leaf production company [Slide 3, Slide 13]. \n* **Long-Term Supply Certainty:** This consists of an officially signed, long-term international supply agreement with a 5-year duration featuring auto-renewal [Slide 14].\n* **Scale of Supply network:** The agreement legally supports and provides access to over 35,000 registered local coca leaf farmers in the Enaco network in Peru [Slide 3, Slide 14].\n* **Preferential Terms:** Harbour has negotiated preferential pricing for all coca leaf and coca leaf derivative products with Enaco [Slide 14]. This secures a consistent and expanding supply exported directly from Peru and imported into Canada [Slide 13].\n* **Proof-of-Concept Seed Importation:** Harbour has already successfully and legally imported decocainized coca leaf extract into Canada/North America for the first time, establishing the operational pathway [Slide 3, Slide 12].\n\n### 2. Proprietary In-House Brand & Product Pipeline (The Launch Portfolio)\nBefore transitioning to commercializing ingredients for external Consumer Packaged Goods (CPG) brands, Harbour is seeding its commercial operations with its own suite of proprietary brands [Slide 3]:\n* **Ratio (Brand):** A proprietary brand focused on performance and health, starting with \"Pure Plant Protein\" (a plant-based protein powder delivering 20g of protein and 100 calories per serving) [Slide 29, Slide 34].\n* **Constitution Nutraceuticals (Brand):** A proprietary brand launching \"Whole Body Vitality\" chewable tablets, which are plant-based dietary supplements utilizing coca leaf extract [Slide 30, Slide 34, Slide 35].\n* **Harbour Nootropic Beverages (Brand):** A proprietary brand of functional beverages [Slide 31]. The product line includes distinct SKUs such as:\n * \"ZZZZZ\" (coca leaf, damiana, and sarsaparilla active ingredients) [Slide 31, Slide 32, Slide 33]\n * \"Rough Night\" [Slide 32, Slide 33]\n * \"Hunker Down\" [Slide 32, Slide 33]\n * \"Mirror Mirror\" [Slide 32, Slide 33]\n * \"Super Excellent\" [Slide 32, Slide 33]\n * \"Get Some\" [Slide 32]\n * \"Warm Blanket\" [Slide 32]\n* **Launch Roadmap:** The initial launch portfolio consists of four primary internal products: an energy drink beverage, a lifestyle coca-infused water, a single-serve protein powder, and an energy shot [Slide 3].\n\n### 3. Pre-Identified Commercial & Distribution Pipeline\n* **CPG Brands Pipeline:** Harbour is in active, current discussions with several established CPG brands across North America to supply non-active coca leaf extracts [Slide 3].\n* **Distribution Contracts:** Distribution contracts for Harbour's in-house suite of brands (Ratio, Constitution, and Nootropic Beverages) are currently in the final stages of negotiation [Slide 3].\n* **Target Commercial Verticals:** The company has pre-identified and targeted key commercial customers across active pharmaceutical ingredients (APIs) and non-active extracts [Slide 23]:\n * **Active Compounds (Alkaloids):** Target pipeline pharmaceutical customers under independent Health Canada approved licenses include Sun Pharma, Apotex, GSK, and Taro [Slide 23].\n * **Non-Active Extracts:** Target pipeline commercial partners for flavor and consumer goods include Coca-Cola, Cott (for Walmart), Red Bull, Aesop, Tom Ford, and LUSH [Slide 23].\n\n### 4. Seeded Infrastructure & Real Estate Pipelines\n* **Brampton processing Facility Option:** Harbour has secured formal municipal support from Mayor Patrick Brown of Brampton, Ontario, to build its major processing facility and global corporate headquarters in the city of Brampton [Slide 22].\n* **Strategic Collocation:** The pre-identified facility location in Brampton is chosen for its proximity to key future stakeholders and logistics hubs, including Coca-Cola and Sun Pharmaceuticals [Slide 22].\n* **Academic/R&D Pipeline:** Harbour has developed plans to build a research arm to support co-op programs with Toronto Metropolitan University’s School of Medicine and Sheridan College [Slide 22].",
"citations": [],
"payload": {
"warehoused_deals": {
"pipelineCompanies": [
{
"coInvestors": [],
"companyName": "Enaco",
"description": "Empresa Nacional de la Coca, the Peruvian state-run coca leaf production company with an officially signed 5-year long-term international supply agreement with auto-renewal.",
"headquarters": "Peru",
"sector": "Agriculture",
"source": "Proprietary",
"status": "Closed"
}
]
}
}
},
"schemaKey": "warehoused_deals"
}
]
},
"slides": [],
"teamSourceUrls": []
},
"success": true,
"targetFundName": "Harbour IR Deck Nov2023 2 (1)",
"team": [],
"team_data": {
"extendedTeamMembers": [],
"firmLeadership": [],
"keyPrincipals": [],
"metadata": {
"sourceUrls": [],
"totalTeamMembers": 0
},
"otherFirmMembers": [],
"sourceUrls": [],
"unifiedTeamList": [],
"websiteResearchMeta": null
},
"tigris_store_files": [
{
"developer_name": null,
"display_name": "report_pitch_deck_schema_fund_overview_and_terms.md",
"entity_name": "harbour_ir_deck_nov2023_2__1_",
"environment": "production",
"evaluation_metadata": {},
"file_size": 6746,
"key": "funds/harbour_ir_deck_nov2023_2__1_/27/report_pitch_deck_schema_fund_overview_and_terms.md",
"mime_type": "text/markdown",
"run_id": "27",
"store_name": "tigris",
"system": "trigger",
"task_name": "pitch_deck_schema_fund_overview_and_terms",
"topic": "fund_harbour_ir_deck_nov2023_2__1_",
"url": "tigris://funds/harbour_ir_deck_nov2023_2__1_/27/report_pitch_deck_schema_fund_overview_and_terms.md"
},
{
"developer_name": null,
"display_name": "metadata_gemini.parquet",
"entity_name": "harbour_ir_deck_nov2023_2__1_",
"environment": "production",
"evaluation_metadata": {},
"file_size": 15667,
"key": "funds/harbour_ir_deck_nov2023_2__1_/27/gemini-file-store-meta/metadata_gemini.parquet",
"mime_type": "application/vnd.apache.parquet",
"run_id": "27",
"store_name": "tigris",
"system": "trigger",
"task_name": "metadata-parquet-export",
"topic": "fund_harbour_ir_deck_nov2023_2__1_",
"url": "tigris://funds/harbour_ir_deck_nov2023_2__1_/27/gemini-file-store-meta/metadata_gemini.parquet"
},
{
"developer_name": null,
"display_name": "report_pitch_deck_schema_strategy_and_portfolio.md",
"entity_name": "harbour_ir_deck_nov2023_2__1_",
"environment": "production",
"evaluation_metadata": {},
"file_size": 12713,
"key": "funds/harbour_ir_deck_nov2023_2__1_/27/report_pitch_deck_schema_strategy_and_portfolio.md",
"mime_type": "text/markdown",
"run_id": "27",
"store_name": "tigris",
"system": "trigger",
"task_name": "pitch_deck_schema_strategy_and_portfolio",
"topic": "fund_harbour_ir_deck_nov2023_2__1_",
"url": "tigris://funds/harbour_ir_deck_nov2023_2__1_/27/report_pitch_deck_schema_strategy_and_portfolio.md"
},
{
"developer_name": null,
"display_name": "metadata_gemini.parquet",
"entity_name": "harbour_ir_deck_nov2023_2__1_",
"environment": "production",
"evaluation_metadata": {},
"file_size": 20285,
"key": "funds/harbour_ir_deck_nov2023_2__1_/27/gemini-file-store-meta/metadata_gemini.parquet",
"mime_type": "application/vnd.apache.parquet",
"run_id": "27",
"store_name": "tigris",
"system": "trigger",
"task_name": "metadata-parquet-export",
"topic": "fund_harbour_ir_deck_nov2023_2__1_",
"url": "tigris://funds/harbour_ir_deck_nov2023_2__1_/27/gemini-file-store-meta/metadata_gemini.parquet"
},
{
"developer_name": null,
"display_name": "report_pitch_deck_schema_team_and_track_record.md",
"entity_name": "harbour_ir_deck_nov2023_2__1_",
"environment": "production",
"evaluation_metadata": {},
"file_size": 6409,
"key": "funds/harbour_ir_deck_nov2023_2__1_/27/report_pitch_deck_schema_team_and_track_record.md",
"mime_type": "text/markdown",
"run_id": "27",
"store_name": "tigris",
"system": "trigger",
"task_name": "pitch_deck_schema_team_and_track_record",
"topic": "fund_harbour_ir_deck_nov2023_2__1_",
"url": "tigris://funds/harbour_ir_deck_nov2023_2__1_/27/report_pitch_deck_schema_team_and_track_record.md"
},
{
"developer_name": null,
"display_name": "metadata_gemini.parquet",
"entity_name": "harbour_ir_deck_nov2023_2__1_",
"environment": "production",
"evaluation_metadata": {},
"file_size": 14293,
"key": "funds/harbour_ir_deck_nov2023_2__1_/27/gemini-file-store-meta/metadata_gemini.parquet",
"mime_type": "application/vnd.apache.parquet",
"run_id": "27",
"store_name": "tigris",
"system": "trigger",
"task_name": "metadata-parquet-export",
"topic": "fund_harbour_ir_deck_nov2023_2__1_",
"url": "tigris://funds/harbour_ir_deck_nov2023_2__1_/27/gemini-file-store-meta/metadata_gemini.parquet"
},
{
"developer_name": null,
"display_name": "report_pitch_deck_schema_warehoused_deals.md",
"entity_name": "harbour_ir_deck_nov2023_2__1_",
"environment": "production",
"evaluation_metadata": {},
"file_size": 4958,
"key": "funds/harbour_ir_deck_nov2023_2__1_/27/report_pitch_deck_schema_warehoused_deals.md",
"mime_type": "text/markdown",
"run_id": "27",
"store_name": "tigris",
"system": "trigger",
"task_name": "pitch_deck_schema_warehoused_deals",
"topic": "fund_harbour_ir_deck_nov2023_2__1_",
"url": "tigris://funds/harbour_ir_deck_nov2023_2__1_/27/report_pitch_deck_schema_warehoused_deals.md"
},
{
"developer_name": null,
"display_name": "metadata_gemini.parquet",
"entity_name": "harbour_ir_deck_nov2023_2__1_",
"environment": "production",
"evaluation_metadata": {},
"file_size": 13218,
"key": "funds/harbour_ir_deck_nov2023_2__1_/27/gemini-file-store-meta/metadata_gemini.parquet",
"mime_type": "application/vnd.apache.parquet",
"run_id": "27",
"store_name": "tigris",
"system": "trigger",
"task_name": "metadata-parquet-export",
"topic": "fund_harbour_ir_deck_nov2023_2__1_",
"url": "tigris://funds/harbour_ir_deck_nov2023_2__1_/27/gemini-file-store-meta/metadata_gemini.parquet"
},
{
"developer_name": null,
"display_name": "report_extracted_sec_entities.md",
"entity_name": "harbour_ir_deck_nov2023_2__1_",
"environment": "production",
"evaluation_metadata": {},
"file_size": 1181,
"key": "funds/harbour_ir_deck_nov2023_2__1_/27/report_extracted_sec_entities.md",
"mime_type": "text/markdown",
"run_id": "27",
"store_name": "tigris",
"system": "trigger",
"task_name": "extracted_sec_entities",
"topic": "fund_harbour_ir_deck_nov2023_2__1_",
"url": "tigris://funds/harbour_ir_deck_nov2023_2__1_/27/report_extracted_sec_entities.md"
},
{
"developer_name": null,
"display_name": "metadata_gemini.parquet",
"entity_name": "harbour_ir_deck_nov2023_2__1_",
"environment": "production",
"evaluation_metadata": {},
"file_size": 11079,
"key": "funds/harbour_ir_deck_nov2023_2__1_/27/gemini-file-store-meta/metadata_gemini.parquet",
"mime_type": "application/vnd.apache.parquet",
"run_id": "27",
"store_name": "tigris",
"system": "trigger",
"task_name": "metadata-parquet-export",
"topic": "fund_harbour_ir_deck_nov2023_2__1_",
"url": "tigris://funds/harbour_ir_deck_nov2023_2__1_/27/gemini-file-store-meta/metadata_gemini.parquet"
}
],
"totalCostUsd": 0,
"verification_and_claims": {
"sec_diligence": {
"discoveredEntities": {},
"fundName": "Harbour IR Deck Nov2023 2 (1)",
"metrics": {
"successfulExtractions": 0,
"totalCostFormatted": "$0.000206",
"totalCostUsd": 2.055e-4,
"totalDurationMs": 0
},
"primaryDocs": [],
"savedFiles": [],
"secExecutives": [],
"secWebsiteUrls": []
}
},
"websiteResearchMeta": null
}